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Maternal obesity and multiple births have adverse effects on fetal growth; prevalence of both are 
increasing in Canada.  We explored associations between maternal obesity and infant size for gestational 
age using data from a London perinatal database. Birthweight for gestational age was assessed using 
standards published by Robertson (2002) to classify Small for Gestational Age (SGA) and Large for 
Gestational Age (LGA) in 30396 singletons and 1346 twins. Associations were estimated using logistic 
regression for singletons and the GEE extension of logistic regression for twins. Increased maternal pre-
pregnancy BMI was statistically significantly associated with decreased odds of SGA in singletons (p< 
0.0001), and increased odds of LGA in singletons and twins (p< 0.0001, p= 0.0004 respectively). Results 
suggest that maternal BMI may influence size for gestational age differently in singleton and twins. 
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The St. Josephs’ Health Care and London Health Sciences Centre Perinatal Database contains valuable 
information on pregnant mothers and their newborns.   
We used this database to explore mothers’ body mass index (BMI), and how this affected growth of their 
babies. While this has been studied in singleton babies (babies that are born following a pregnancy where 
the mother carried only a single baby), it has not been studied in babies who are twins.  
As an additional objective, we wanted to know if mothers’ BMI affected the growth of singleton and twin 
babies in similar ways. A twin pregnancy can be more complicated for the mother, the babies, and the 
doctors taking care of them, compared to a singleton pregnancy.   For this reason, twins are often 
excluded from research studies.  We wanted to compare singleton and twin pregnancies because many 
studies exclude twins from their research.   
We focused on mothers’ BMI because this can be related to other medical conditions that can harm the 
pregnancy.  To study growth, we used a measure known as “Size for Gestational Age, which assesses the 
newborn’s weight at birth, relative to the weight we expect for a baby born from a pregnancy of this 
length (gestational age).  This measure allows us to better compare newborn growth.   Newborns with 
below-normal rates of growth are “Small for Gestational Age (SGA)” while newborns with above-normal 
rates of growth are “Large for Gestational Age (LGA)” compared to the population. Identifying SGA and 
LGA newborns can help doctors recognize newborns that might need further health care.   
We found that heavier mothers were more likely to have a bigger, or LGA singleton or twin baby, and 
less likely to have a smaller, or SGA singleton baby.  However, it is important to remember that some 
heavier mothers can still have smaller babies, and that some thinner mothers can still have larger babies. 
This was previously known for singletons, but we found this also to be true for twins. Our results were 
unable to determine conclusively whether this may just be a random finding because the number of twins 
in our study was small.  Therefore. further study is required. These results are important, because they can 
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This thesis research was undertaken to explore the role of maternal obesity in determining fetal 
growth in twins and singletons.  While, to some degree, studies have examined the relationship between 
maternal obesity and fetal growth in singletons, there remain some gaps in understanding this 
relationship.  To date, the relationship between maternal obesity and fetal growth has not been studied in 
twins in this population.  Incorporating a comparison between twins and singletons furthers the topic.  
Using data from a London Ontario based perinatal database from June 1st 2006, to August 31st 
2018, this research explored the association between maternal Body Mass Index (BMI) and infant size for 
gestational age, in singletons and in twins, with consideration of whether the associations are consistent 
between singletons and twins. Other higher order multiples (triplets, quadruplets etc.) were not included 
owing to increased complications and decreased sample sizes. 
Chapter one consists of 6 sections: Section 1.1 is a general introduction. Sections 1.2 and 1.3 
cover the objectives of this thesis research, section 1.4 presents the hypotheses, and section 1.5 provides a 
rationale for the objectives. Section 1.6 is an outline of the structure of the remainder of the thesis.   
 
1.2 Research Objectives 
Each objective will separately consider singletons and twins.  
The objectives of this thesis are:  
1. To describe pre-pregnancy, pregnancy related, birth and delivery and infant related factors in the 
London Ontario maternal and birth population, stratified by multiple births. 
2. a) To determine the population-specific prevalence of being born in one of three categories: 
Small for Gestational Age (SGA; defined as birth weight <10th percentile for gestational age); 
Appropriate for Gestational Age (AGA; defined as birth weight 10th-90th percentile for gestational 
age) or Large for Gestational Age (LGA; defined as birth weight >90th percentile for gestational 
age), using an external (1) Canadian size for gestational age standard.  
b) To compare these prevalence estimates for infants born to mothers across six maternal BMI 





(BMI 25.0-29.99); and obese (class I: BMI 30.0-34.99; class II: BMI: 35.0-39.99; class III: BMI 
40.0-60.0)) in singletons and in twins.  
3. To identify whether there is an association between maternal pre-pregnancy BMI class and infant 
size for gestational age in singletons and in twins, after adjustment for relevant confounders. 
4. To explore the effects of multiple births on modifying the association between maternal pre-
pregnancy BMI class and infant size for gestational age.  
 
1.3 Hypotheses 
It was hypothesized that an association would be present between maternal BMI and infant size 
for gestational age.  In particular, decreasing maternal BMI was hypothesized to be associated with 
decreasing size for gestational age, and increasing maternal BMI was hypothesized to be associated with 
increasing size for gestational age.   
 
1.4 Rationale 
Both maternal obesity and multiple births can have an adverse effect on fetal growth. 
Fetal growth and size are significant determinants of health (2,3).  Increased risks of morbidity 
and mortality exist for both excessively and insufficiently grown babies(4–7), as opposed to those that are 
‘optimally’ grown (8–10).  Fetal size for gestational age is one measure that allows for assessment of fetal 
growth that incorporates birthweight and gestational age.  
According to Canadian Community Health Survey data, as of 2014, 27.5% of Canadian women 
reported being overweight, and 18.7% of women reported being obese (11), and the prevalence of obesity 
in the population has been increasing (12).  Maternal BMI status can significantly influence fetal growth 
and size, and also increases risks of adverse maternal and fetal and delivery-related events (13–16). 
Rates of twin births are also increasing, with 3.3% of all births in Canada being multiple births in 
2011, as compared to 2.1 % in 1991 (17).  Growth trajectories in utero can vary in twins and higher order 
multiples as compared to singleton pregnancies  (18,19). Twin and multiple births can be at increased risk 
of adverse events as compared to singleton births (20).  Twin growth in utero is understudied, due to the 
increased statistical complexity required.  
The effect of growth restriction due to multiple gestations, combined with the influence of 





infants to be studied.  Infants born to obese mothers are at risk of different health outcomes than those 
born to mothers with ‘normal’ BMI, which are different from those born to mothers with underweight 
BMI.  These risks can increase the further an infant deviates from their optimal growth (21,22), and 
increase further still in multiple gestations (23).   While some studies have explored outcomes of obesity 
in twin births(24), few studies to date have explored the combination of these factors on fetal growth and 
size for gestational age.  
It is unclear how infant size for gestational age is influenced by maternal obesity class and 
multiple births. Results from this study aim to explore the potential associations between maternal obesity 
and fetal size for gestational age in singleton and multiple pregnancies and have the potential to inform 
clinical practise.  
 
1.5 Thesis Structure 
This thesis is written in the monograph format following the Western University School of 
Graduate and Postdoctoral Studies guidelines. 
Chapter 1 is an introduction to the thesis and discusses objectives, hypotheses and rationale.  
Chapter 2 presents the literature review discussing the three main topics; fetal growth, maternal obesity 
and multiple births. Chapter 3 outlines the various methods used in this thesis project, while Chapter 4 
describes the results, by objective.  Chapter 5 concludes the thesis, discussing the findings, as well as 
strengths, weaknesses and future directions of the project.  Finally, appendices of topics relevant to this 






2 Chapter 2 – Literature Review  
 
2.1 Overview  
This chapter presents the background information relevant to the thesis topic and identifies the 
gaps to be studied.   Given the importance of the measures of fetal growth, section 2.2 presents the 
overarching framework whereby modern literature distinguishes between fetal size and fetal growth, the 
latter being one of two major contributors to the former.  The remainder of the chapter is divided into 3 
relevant sections; Section 2.3 discussing fetal growth, the key outcome focus of this study, and sections 
2.4 and 2.5 discussing maternal obesity and twin birth, respectively, as the two key predictive factors of 
interest in this study.   
 
2.2 Fetal Size at Birth is Reflective of Gestational Age and Fetal Growth 
Relative to Gestational Age 
Historically, clinicians and researchers were interested in measuring fetal size at the time of birth 
as an important predictor of fetal health.  Birth weight is amongst the strongest factors related to infant 
mortality and survival (4,22).  Low birth weight is diagnosed at birth weights less than 2500g (5,25), 
owing to the increased risks of mortality and other adverse health outcomes occurring below this 
threshold (4), with a 2004 UNICEF publication reporting that the risk of death is increased 20 times in 
babies with birth weights below 2500g (5), as compared to babies with higher birthweights.  Macrosomia, 
a term used to describe excess birth weight, has been defined as birth weight above 4000 grams, and more 
recently as above 4500g (26), as adverse health risks for both mother and child increase significantly at 
birth weights above 4500g (6,26).  Therefore, a ‘typical’ birth weight is considered to be 2500g to 4000g.  
Risks of adverse health outcomes are generally lower within this birthweight range(8–10).  However, 
neither macrosomia nor low birth weight account for gestational age at birth.  Using birth weight alone 
does not allow clinicians to distinguish between unusual birth weight due to gestational age vs. due to an 
altered growth rate, and also has the potential to overlook or hide trends over time (27).   
Gestational age is considered amongst the main determinants of birthweight (4,22,28). Term 
births occur between 37-40 weeks gestational age; Preterm births occur prior to 37 weeks; and post term 
births occur past 42 weeks gestational age (29).  Gestational age at birth can be related to many adverse 
health outcomes in both mother and child (30,31).  
The fetus’ growth rate in utero and total duration of gestation are the two factors that combine to 





spent in utero, insufficient growth rate in utero, or a combination of the two factors.  At the other end of 
the birth weight spectrum, excess birth weight can be due to additional time spent in utero, a higher 
gestational growth rate, or a combination of the factors.  Given a desire to differentiate these two factors, 
newer literature looks separately at gestational age and fetal growth as two independent constructs 
shaping fetal size at birth. 
 
Modern literature therefore relies on measures of fetal growth have evolved which are based on 
birthweight for gestational age as compared to a standard distribution. Size for gestational age classifies 
birth weight for gestational age into three categories; small for gestational age (SGA) births are defined as 
those below the 10th percentile for the population,  appropriate for gestational age (AGA) births are 
defined as those between the 10th to 90th percentiles, and large for gestational age (LGA) births are greater 
than the 90th percentile (32). These measures can be developed as population standards, which are based 
on normal pregnancies only, or as population references, which are based on both normal and 
obstetrically complex pregnancies(2), and are constantly updated to reflect changing trends in maternal 
health and subsequent fetal growth.  
Some authors state that there is no such thing as a ‘normal’ preterm birth (33–35). Many studies 
have suggested a link between poor intrauterine growth and preterm birth (36–41).   
 
2.3 Fetal Growth  
 
2.3.1 Introduction 
Fetal growth and size are significant determinants of health (2).  Events that occur in the 9 months 
of gestation can go on to determine later life health as well (42–44). This section will outline key 
developmental stages of uterine growth, normal vs. abnormal fetal growth trajectories, the risk factors that 
can lead to abnormal fetal growth and following outcomes, and common measures and clinical diagnoses 
used to quantify fetal growth.  
 
2.3.2 What is ‘Normal’ (Typical) Fetal Growth? 
Fetal growth is influenced by genetic and environmental factors (44–46) with maternal, fetal, and 
placental health, all having an effect on growth potential (47).  Abnormal fetal growth is any increase or 





between these main factors(2,21). Fetal developmental milestones such as those published by the US 
National Library of Medicine (48), provide estimates of fetal size by gestational age and can be used to 
determine whether a fetus is on the ‘right track’ for growth.  It is important to note that these gestational 
milestones are not concrete; different fetuses of similar gestational age will not necessarily develop at 
exactly the same rate(49). The following section outlines key terms that can be used to describe normal 
and abnormal growth.    
 
2.3.3 Fetal Development  
Langman’s Medical Embryology (50) provides an in depth overview of singleton fetal 
development. Following is a quick overview relevant to this thesis.  ‘Normal’ fetal development begins 
with fertilization at day 0 with the combination of male and female haploid gametes. Once combined, 
both maternal and paternal chromosomes double and split, forming a two-celled mass called a zygote 
containing the typical diploid number of chromosomes. This two cell stage of the zygote forms 
approximately 30 hours after fertilization.   Following this, the cells further divide, in a process known as 
cleavage. These cleaved cells are known as blastomeres. The four cell stage of the zygote forms at 
approximately 40 hours. Blastomeres form a loose ‘clump’ prior to the 8 cell stage, after which they join 
together in a process called compaction. By 3 days post-fertilization, the compacted zygote grows to 
develop a 12 to 16 cell sized morula.  Fluid enters the morula causing the separation of the outer cell mass 
of trophoblast from the inner cell mass called the embryoblast.  The amniotic cavity forms within the 
inner (epiblast) cell layer of the embryoblast.  The outer cells of the morula will develop into the 
trophoblast. This occurs by the 8th day post fertilization. Following this, the zygote can begin implantation 
in the uterine wall. The chorionic cavity will form by the 11th or 12th day post fertilization from cells 
derived from the trophoblast. The chorionic cavity surrounds the amniotic cavity. 
The third to eighth weeks are referred to as the embryonic period, where the ectodermal, 
mesodermal and endodermal germ layers continue further differentiating.  During this period the fetus 
experiences rapid growth in both length and weight of the body, which can be measured as the crown-
rump-length (CRL), as well as a slowing of growth of the head, relative to the rest of the body. Major 
organ structures will form during this period. 
The fetal period occurs from the 8th week of development onwards. At this time, major organs 
and systems continue to develop. Fetal weight increases rapidly in the second half of gestation (i.e. month 
5 onwards), with the majority of weight increase occurring in the last 2.5 months. Growth generally 





difficulty of surviving, due to underdevelopment of the central nervous system and respiratory system, as 
well as lack of communication between the two essential systems.  However, a fetus born in the 7th month 
of gestation will have an approximately 90% chance of survival.  At this time, the fetus will have, on 
average, a 25 cm CRL, and can weigh around 1100g.  By birth, the fetus will weigh anywhere from 2500-
4000g and will have a CRL of approx. 36 cm and crown-heel-length (CHL) of approximately 50 cms 
(50).   
Please refer to the US National Library of Medicine (48) for an overview of fetal development by 
week, and Williams Obstetrics 24th edition(49) , and Langmans’ Medical Embryology 12th edition  (50)  
for an in depth discussion on the topic.   
 
2.3.4 Abnormal Fetal Growth  
In contrast, abnormal fetal development can be defined as fetal growth that does not follow these 
common milestones. It is important to note that abnormal growth is not necessarily dangerous; many 
babies will be born slightly above or below the ideal range that are healthy (21).  Abnormal development 
can be caused by a number of factors and can lead to multiple outcomes such as miscarriage, preterm 
birth, and congenital abnormalities -further outlined in sections 2.2.4 and 2.2.5.   
 
2.3.5 Pathologically vs Constitutionally Determined Size  
Not all abnormally grown babies will be at risk for further adverse health outcomes and not all 
will be so due to any underlying pathology (21).   It is important to be able to distinguish between infants 
that are pathologically large, versus infants that are simply constitutionally large.   Constitutionally large 
infants may have been born to larger parents, and may not necessarily have experienced overgrowth, 
when considered relative to their parents size  (21,51). Pathologically large infants can go on to 
experience later life adverse events, possibly due to metabolic consequences that led to excess fetal 
growth in a poor uterine environment (52).  A 1995 study determined that anthropometric  measurements, 
such as a higher quadriceps skinfold thickness can be used to identify LGA infants at risk of adverse 
health events (53).   
Likewise, infants can also be pathologically or constitutionally small(54,55). Using customized 
birthweight standards allows for more accurate identification of pathologically small infants (54,56), with 
one American birth population study determining that 17.4% of infants diagnosed as SGA were only 
constitutionally small, and were not at risk for any complications (57). These results have been replicated 





can be helpful in differentiating infants that are more likely to be pathologically small, however, not all 
SGA infants are so due to IUGR (21). An American study on 19 million singleton births suggested that in 
early preterm, SGA could be a proxy for growth restriction (i.e. more likely to be pathologically small), 
and that at term SGA babies were more likely to just be constitutionally small (62). Infants identified as 
SGA that have normal umbilical artery Doppler flow results were more likely to be constitutionally small, 
as compared to SGA infants with abnormal Doppler flow results in a 2000 study (63), and confirmed in 
another study (64).  Lower quadriceps skinfold thickness can be used to detect pathologically SGA infants 
(53). Maternal placental functioning can also be key in identifying IUGR and pathologically small infants 
(47) and gestational age at birth can also play a role in determining whether infants’ size is pathological.  
A 2009 study suggested that when SGA babies are born at term they were more likely to be 
constitutionally small, whereas when SGA babies are born preterm, they were more likely to be SGA due 
to IUGR (62).  
 
2.3.6 Measures of Fetal Growth 
There are many ways to measure fetal growth. Measures such as birth weight, crown rump length, 
bi-parietal diameter, femur length, head circumference, and abdominal circumference are simple 
measurements that have potential to reflect if a newborns size falls outside of a normal range. More 
complex measures, such as size for gestational age take into account fetal weight relative to gestational 
age at birth, and are better able to capture abnormal growth, and infants in need of special care (65).  
 
2.3.6.1 Size for Gestational Age  
Infant Size for Gestational Age, relative to a birth population, is a measure that incorporates 
infant size as well as their gestational age and sex.  
Size for gestational age is a population-based measure that can be further refined to take into 
account essential variables such as maternal ethnicity and BMI to create more customized values (62). An 
infant is classified as small for gestational age (SGA) if they are below the 10th percentile for their given 
gestational age; large for gestational age (LGA) infants will be greater than the 90th percentile for the 
given gestational age and appropriate for gestational age (AGA) infants will fall between the 10th and 90th 
percentiles for the given gestational age.  The term small for gestational age is often used as a proxy for 
discussing fetal growth restriction. Table 2.1 below outlines the 10th and 90th percentile cutoffs (in grams) 
at 37 weeks gestational age for the standard used in this study (Robertson, 2002), as well as other 





2001) defines the 10th percentile cutoff at 37 weeks as 2452g for female infants, and 2552g for male 
infants. The 90th percentile cutoff is 3542g for female infants and 3665g for male infants born at 37 weeks 
gestation (32).  
 
Table 2. 1 10th and 90th percentile cutoffs (in grams) at 37 weeks gestational age 























































*note that Kramer 2001 only assessed singletons 
+Ghi 2017 did not stratify by sex  
**Ghi cutoffs are reported for 36 weeks (37th week and further were not assessed in that study) 
 
SGA and LGA are not diagnoses, rather, they are simply benchmarks that have the potential to 
alert to underlying conditions. SGA will capture babies that are below the 10th percentile that are still 
healthy, and can fail to capture a growth restricted baby that still classifies as average for gestational age 
relative to the population (21). Not all SGA babies will be growth restricted, and not all growth restricted 
babies will be classified as SGA(21,66). For example, growth restriction can cause a fetus to drop from 
the 70th percentile to the 50th percentile; while this could be due to growth restriction, the baby will not be 
classified as SGA (21,67), however, it could be argued that this baby is at increased risk of adverse health 
outcomes as compared to a baby that was consistently growing at the 7th percentile of birthweight for 
gestational age (68). Maternal and fetal genetic factors and their environmental interactions can account 





value is the fact that it will include infants that are SGA, as well as preterm births, since it does not 
account for gestational age.   
The 10th and 90th percentile cutoffs are not concrete; they are simply one set of ‘tail ends’, or 
extremes of the population distribution of size for gestational age at birth, however, these are the most 
commonly used values when defining adverse size for gestational age. Values such as the 5th and 95th or 
the 3rd and 97th percentiles cutoffs can also be used (69); the tighter cutoffs have the potential to capture 
the most extreme cases of abnormal growth.  There is no  consensus as to which cutoffs to use, however, 
rates of adverse health outcomes do increase at extremes of the birth weight for gestational age 
distribution (70,71). Mayer and Joseph (2), discuss that setting certain percentile points as cutoffs for 
SGA or LGA wrongly implies that the rate of growth restriction is constant across all gestational ages.    
 
2.3.7 Excess Fetal Growth  
Excess fetal growth is rapidly becoming a common clinical concern.  Excess fetal growth can be 
defined as growth greater than 4000g – a birth weight of 4000g is equivalent to the 90th percentile at 40 
weeks gestational age (72). Excess growth may also be diagnosed if a fetus is LGA; similar to the 
limitations of the SGA definition, the LGA measure has the potential to capture both fetuses at higher risk 
for adverse health outcomes related to increased size, as well as ‘normal’ fetuses not at increased risk 
(73). Excessively grown fetuses may not necessarily be categorized as LGA and not all LGA infants will 
be excessively grown.    It is difficult to predict macrosomia with certainty in a routine checkup, 
therefore, knowing the determinants is essential for effective management.  This section will cover 
determinants of excess fetal growth, as well as related post birth maternal and fetal outcomes. Excess fetal 
growth is a cause for concern because it leads to many adverse maternal and fetal outcomes requiring 
further clinical management.  
 
2.3.7.1 Determinants of Excess Growth  
Excess growth is usually determined by the gestational environment. Excess growth can be 
associated with multiple factors (74), which can be divided into constitutional, metabolic and placental 
factors.   The main maternal factors related to fetal macrosomia are parity, pre pregnancy BMI, 
gestational weight gain, prior macrosomic or LGA births and ethnicity. Maternal metabolic factors 
include maternal pre-pregnancy diabetes, gestational diabetes, and fasting plasma glucose levels. A 








Parity is a well-known factor in determining birth weight. Nulliparous women are at increased 
risk (OR: 1.41, 95%CI: 1.26-1.58) of giving birth to infants with lower birth weight, as well as increased 
risk (OR: 1.89, 95%CI: 1.82-1.96) of giving birth to SGA infants than multiparas (75,76).  A 2008 study 
found that multiparous women were more likely to give birth to a high birth weight infant, with 71.2% of 
births greater than 5000g to multiparous mothers (77).  In a study of consecutive pregnancies, an increase 
of 138g mean crude birthweight was measured from first to second pregnancies (78). The effect of parity 
on birthweight is thought to be non-linear, with the steepest increase in birthweight occurring from first to 
second pregnancies (76). Parity is closely tied to maternal age (4), obesity(79),  and socioeconomic status 
(80).  
 
Maternal Pre-pregnancy BMI 
The role of maternal Body Mass Index is well known in predicting birth weight and size for 
gestational age. Studies have found a strong association between increasing maternal BMI, and increasing 
offspring birthweight (as well as increasing size for gestational age) (81–87). Pre-pregnancy BMI is a 
main variable in this study, and is described in further detail in section 2.3.   
 
Gestational Weight Gain 
Increasing gestational weight gain is associated with increasing birth weight (84,88,89).  One 
study reported that late gestational weight gain has a stronger positive effect on birth weight than early 
gestational weight gain (90). Excess weight gain related risks of macrosomia are greater for obese 
mothers as compared to non-obese mothers (26).  Excess gestational weight gain (seen in Table 2.2 
below), defined by Institute of Medicine guidelines (91), was found to be a predictor of LGA births, 
independent of the effect of maternal pre-pregnancy BMI in a Canadian population. Overweight and 
obese women demonstrated higher rates of excess gestational weight gain (overweight: > 25lbs; obese: 
>20 lbs. total weight gain), and also demonstrated higher odds of giving birth to LGA infants; with 
overweight women having an odds ratio of 3.59 (95%CI: 2.60-4.95), and obese women having an odds 
ratio of 6.71 (95%CI: 4.83-9.31) as compared to women in the ‘normal’ BMI category that did not exceed 
gestational weight gain guidelines (86). A 2014 study in an Italian population also determined that the 





In morbidly obese women, giving birth to an LGA infant was associated with gestational weight gain 
exceeding 25 lbs., and also found that insufficient gestational weight gain was not associated with lower 
birth weight (92). Lower income mothers are at increased risk for both insufficient and excess gestational 
weight gain (93,94). 
Table 2. 2 Institute of Medicine 2009 Gestational Weight Gain Guidelines 
BMI Category (kg/m2) Recommended Gestational Weight Gain Range (lb) 
Underweight (<18.5) 28-40 
Normal Weight (18.5-24.9) 25-35 
Overweight (25.0 – 29.9) 15-25 
Obese (≥30) 11-20 
 
Previous LGA or Macrosomic Birth  
A mothers’ previous birth history is a non-modifiable risk factor (95) that can influence 
birthweight. Mothers with previous macrosomic births can be anywhere from 3 to 12 times more likely to 
go on to give birth to another macrosomic infant, as compared to women who give birth to normal weight 
infants (95–98).  A 1980 study reported that mothers giving birth to macrosomic infants have higher rates 
of previous birth >4000g, as compared to mothers giving birth to ‘normal weight’ infants, with 33.4% of 
macrosomic infants having a macrosomic sibling, as compared to 3.2% of normal weight infants having a 
macrosomic older sibling (99).  A Canadian case control study reported that prior history of macrosomic 
birth was a significant predictor of subsequent macrosomia, reporting an odds ratio of 9 (95%CI: 5.8-
14.2) (97). This effect persists in infants of diabetic mothers; a 2005 study reported a significant 
correlation between macrosomic first born infants and subsequent macrosomia in the second born sibling 
born to diabetic mothers (p<0.001) (100).  Maternal obesity is also linked to both macrosomia and history 
of macrosomic births (83).  
 
Maternal Ethnicity 
Maternal ethnicity has been found to play a role in determining birthweight (51,101–103) with a 
2002 Norwegian birth registry study reporting higher average birthweights for Norwegian and North 
African mothers, and lower mean birthweights in infants of Vietnamese and Pakistani mothers (104).  A 
2013 study on a United States birth population found that Hispanic mothers in this study gave birth to the 





the highest proportion of infants born LGA (while also being least likely to have a high Prepregnancy 
BMI) (101).  Rates of confounding factors (i.e. maternal BMI, diabetes) can vary significantly across 
ethnic groups (105–108).  The role of ethnicity must be approached with caution, as ethnicity can be 




Maternal diabetes leads to an excess of glucose and insulin to be passed on to the fetus. Fasting 
plasma glucose (FPG) levels are elevated in individuals with diabetes. When this exists in pregnant 
women, the increase in blood sugar is translated in excess to the growing fetus (109).  The Pedersen 
hypothesis (Figure 2.1 below) was developed in 1954 to explain the biological basis of fetal macrosomia 
(110).  In this model, poor maternal glycemic control, possibly caused by pre-existing, or gestational 
diabetes (111), causes increases in maternal blood glucose concentrations. This increased glucose can 
pass through the placenta through to fetal circulation (112), causing fetal hyperglycemia.  Maternal 
insulin does not pass through the placenta, leaving the fetal pancreas responsible for the production of 
insulin, and thus hyperinsulinemia in response to the maternal hyperglycemia. The combined effect of 
fetal hyperglycemia and hyperinsulinemia leads to increases in fetal fat and protein storage, ultimately 
producing an increase in fetal size(113,114). Specifically, “insulin-sensitive tissues” such as muscle and 
adipose tissue as well as the liver and heart can be overgrown due to the hyperinsulinemia, leading to an 
overall increase in birth weight (115).  These effects can increase significantly in the case of a combined 






























(adapted from MACFARLANE 1988 (106) & KAMANA et al. 2015(109)) 
 
Diabetes has been associated with higher birth weights in multiple studies (117–119). A 1990 
study determined that the concentration of insulin found in amniotic fluid was a predictor of fetal 
macrosomia (120). Increasing blood glucose concentrations are associated with increasing birth weights 
in infants of diabetic mothers (109,121,122). A study of 553 pregnancies found an increased maternal 
fasting plasma glucose is associated with a 4.5 times increase for the risk of macrosomia (OR: 4.5, 
95%CI: 1.7-12.5) (macrosomia defined as birth weight above 4200g) (123). This study also found that 
overweight and obese mothers who gave birth to macrosomic infants showed increased fasting plasma 
glucose levels at weeks 14-16 and weeks 30 -32 of pregnancy.  ‘Normal’ sized, or non-macrosomic 
infants born to overweight women showed no similar change in FPG. In this study, maternal 30-32 week 
fasting plasma glucose level was found to be a predictor of fetal macrosomia independent of maternal 
BMI (123). Diabetes is more likely to be present in obese women (92,111,124,125), and is linked to lower 
socioeconomic status (126–128), and increasing maternal age (129). Evidence exists to suggest that twin 





maternal obesity, high gestational weight gain and diabetes are highly comorbid conditions (111,131–
134). 
 
Carbohydrate Disorders  
Evidence exists to suggest that maternal carbohydrate disorders (separate from diabetic 
conditions) can contribute to excess fetal growth.  A 1996 study on a Canadian population reported an 
incidence rate of 6.7% for gestational carbohydrate intolerance (135). Maternal carbohydrate intolerance 
has been found to lead to adverse infant health outcomes such as increased incidence of infant 
macrosomia, LGA, and hypoglycemia and hypocalcemia (136). Specifically, infant LGA and macrosomia 
were more likely in infants of mothers who had carbohydrate intolerance, but a negative gestational 
diabetes diagnosis. The 1995 Toronto Tri-Hospital Gestational Diabetes project also studied maternal 
fetal outcomes in mothers with carbohydrate intolerance and negative diagnosis for overt diabetes. They 
found that these pregnancies had increased rates of fetal macrosomia (137).  A 2001 Danish study also 
found that maternal carbohydrate intolerance (as measured by a 2-hour oral glucose tolerance test) was 
associated with fetal macrosomia, as well as maternal hypertension.  These studies emphasize that mild 
carbohydrate intolerance (below the levels of overt diabetes), can still lead to adverse maternal and fetal 
outcomes (138). Untreated gestational carbohydrate intolerance was found in one study to lead to 
increased rates of LGA in singletons (20%), as compared to mothers who received treatment(135). 
Literature on the topic of carbohydrate intolerance is difficult to interpret at times; some authors use the 
term carbohydrate intolerance to include diabetes, whereas other authors use the term carbohydrate 
intolerance to describe a condition not ‘strong’ enough to be diagnosed as overt diabetes. 
 
Placental Factors 
Placental factors, such as arterial overgrowth in the chorionic plate of obese mothers can 
contribute to increased energy and nutrient exposure for the fetus (139). Maternal arterial development 
(providing blood supply to the placenta) has been found in one 2015 study to determine fetal overgrowth 
(140). Women giving birth to babies over 4500g are more likely to also have higher placental weights, as 
compared to women giving birth to babies under 4500g  (141).  Increased rates of placental growth 
hormone (which is related to insulin-like growth factor and is involved in energy transfer to the growing 






2.3.7.2 Outcomes of Excess Growth  
Adverse outcomes of excess growth can affect both mother and child.  Adverse fetal outcomes 
include stillbirth, perinatal mortality, birth trauma related injuries, cerebral palsy and differential 
adiposity, as well as later life events such as increased risk of giving birth to an LGA infant.  Adverse 
maternal outcomes include complications due to obstructed birth, and major blood loss.  These risks 
generally increase with increasing size at birth.  Asymmetric growth patterns can also occur due to excess 
growth. Other outcomes include low APGAR scores, shoulder dystocia, higher rates of caesarean 




There is an association between increasing size at birth and stillbirth. A 2008 study reported that 
the odds ratio of stillbirth were 2.7 (5%CI: 2.2-3.4) in infants with birthweight 4500-4999g, and 13.2 
(95% CI: 9.8 to 17.7) in infants with birthweight greater than 5000g, as compared to infants born at 3500-
4499 g (77). A 2012 Canadian study (144) found that for infants above the 99th birthweight percentile (i.e. 
extremely LGA), the adjusted OR for stillbirth was 2.2 (95%CI:1.76-2.86), suggesting that extreme fetal 
overgrowth may be a contributing risk factor towards being stillborn. Similarly, an Australian study found 
that births in the 99th percentile of size for gestational age were at higher risk of perinatal mortality as 
compared to average for gestational age (50th -90th percentile) births (145).     
 
Perinatal and neonatal mortality  
High birthweight has also been linked to perinatal mortality; a 2017 study of over 1.9 million 
births in Norway found an “inverted –J pattern” between perinatal mortality and birthweight, with 
macrosomic infants (defined as z-standardized birth weight >+2 SD’s above the mean birth weight) (146).   
A 2008 study found increased odds of early and late neonatal death in infants born greater than 5000g 
(OR: 6.4, 95%CI: 3.9-10.4) of early neonatal death in infants greater than 5000g; (OR: 5.2, 95%CI; 2.9-
9.4) of late neonatal death in infants greater than 5000g, compared to infants born 3500-4499g (77). 
 
Birth trauma 
Birth trauma related injuries include clavicular fractures (26,147), and brachial plexus injuries 





were strongly associated with vacuum delivery, shorter maternal stature, and advanced age in a 2014 
study (149), and infants with birthweights above 4500g were 10 times more likely to experience 
clavicular fractures (150). Increasing birth weight is associated with increased risk of brachial plexus 
injury during delivery in both diabetic and non-diabetic mothers (151).  Erb’s palsy and Duchenne’s palsy 
are spinal injuries related to brachial plexus injury, and are found to be associated with increasing birth 
weight (152). Bryant et al, recently reported that birth weight is not a strong predictor of brachial plexus 
injury in a predominantly African American birth population (153).  Neonatal brachial plexus palsy can 
also occur as a result of fetal macrosomia, and is strongly linked to shoulder dystocia, fetal birthweight 
greater than 5000g for mothers with diabetes, and fetal birthweight greater than 4500g for mothers 
without diabetes. (154). 
Perinatal asphyxia is also associated with fetal macrosomia (155), as well as meconium 
aspiration, assisted ventilation (148), and facial nerve injuries (150). Infants who experience birth traumas 
are more likely to have lower 1- and 5-minute APGAR scores, as compared to non-injured infants (150).  
Bryant et al found that infants at risk for brachial plexus injury were also at higher risk of having low 
APGAR scores (153) and macrosomic infants with low 5 minute APGAR were at increased risk of an 
extended NICU stay (156).  Mode of delivery can also play a role in birth injury incidence (157–160).  
 
Cerebral palsy 
Rates of cerebral palsy have also been found to be 1.5 to 3 fold higher in births above the 97th 
percentile for size for gestational age (2,161). A 2013 study found that cerebral palsy in larger infants 
may be due to delivery related factors (162). 
 
Later Life Adverse Health  
Fetal macrosomia can lead to later life poor health and obesity. Later life obesity in macrosomic 
infants is more likely, than in infants born at ‘normal weight’ (81). One 1990 study in a United States 
population suggested that fetuses exposed to excess gestational insulin were predisposed to later obesity 
by age 6 (120).  Another study found a strong association between higher maternal BMI during gestation 
and higher offspring BMI  at age 14 (109,163).  Fetuses exposed to a diabetic intrauterine environment  
experience changes in pancreatic β-cell function, leading to lifelong changes in glucoregulation 
(109,120,164).  One study found that mothers born LGA themselves were more likely to have an 
increased BMI in adulthood; when the mothers birth weight for gestational age was 2.0 standard 





1.50 (95%CI: 1.39-1.61), and the adjusted odds for later life class I obesity (BMI: 30.0-34.9) was 1.77 
(95%CI: 1.59-1.98).  These same mothers were also found to be more likely to go on to give birth to LGA 
infants; overweight mothers with a birth weight greater than 2.0 SD above mean have an odds ratio of 
8.43 (95%CI: 6.00-11.85), and obese mothers with a birth weight greater than 2.0 SD above the mean 
have an odds ratio of 14.14 (95%CI: 9.59-20.83) of giving birth to an LGA infant compared to mothers 
born appropriate for gestational age (81). These results were replicated in a 2011 study in a Swedish birth 
population (81), and in a 2013 European population (165). 
 
Asymmetric Growth in Macrosomic Infants  
Asymmetric growth is another outcome of fetal macrosomia.  Studies on macrosomic infants 
have found them to have a higher relative amount of adipose tissue as compared to normal weight or low 
birth weight fetuses (2).  In mothers with poor glycemic control, there is an increased risk of giving birth 
to a macrosomic infant with increased volume of subcutaneous fat (155). A 2006 study (166) discovered a 
positive association between maternal fasting glucose levels in the third trimester and increased birth 
weight. Macrosomic infants of diabetic mothers grow differently than those of non-diabetic mothers. In 
diabetic mothers, macrosomic infants will have asymmetric growth of the abdominal circumference(AC) 
(120,155). These infants will also have higher amounts of muscle and fat in the abdominal and scapular 
areas compared to macrosomic infants of non-diabetic mothers. These features can contribute to an 
increased risk of shoulder dystocia during delivery (155).  Asymmetric growth related to GDM is thought 
to occur due to differential sensitivities of fetal tissues to insulin. Fetal symmetry can be determined using 






, further described in the 
methods section of Metzger 1990 (120).  A value of 1.0 indicates symmetrical skeletal growth relative to 
adipose tissue, and higher values represent asymmetric growth.  Some authors question the clinical utility 
of investigating fetal growth symmetry (167). 
 
Birthweight over 5000g  
A study of 182 infants with birthweight greater than 5000g reported many adverse fetal and 
maternal outcomes.  Neonatal poor outcomes related to birthweight over 5000g include a significantly 
lower number of infants with APGAR scores greater than 7 (The APGAR score is a quick measure of 
newborn overall health at the 1st and 5th minutes after birth. Scored out of 10, it measures Appearance, 
Pulse, Grimace, Activity and Respiration (168)), shoulder dystocia, and clavicular fractures due to birth 





Maternal Outcomes  
Adverse maternal outcomes related to fetal overgrowth include complications due to obstructed 
birth, and major blood loss. Because macrosomia cannot be accurately diagnosed prior to birth (155), 
delivering an infant over 4000g will present significant and perhaps unexpected challenges during 
delivery. Obstructed labour is becoming increasingly common in the case of overgrown fetuses with 
smaller mothers (140). A study of infants weighing over 5000g at birth reported adverse maternal 
outcomes including increased rates of episiotomies, sphincter injuries, and blood loss over 1000mL (147). 
Maternal adverse outcomes related to operative deliveries due to fetal macrosomia include postpartum 
hemorrhage (157), postpartum infections and anal sphincter lacerations (148,159).  Major blood loss has 
been found to be associated with higher birthweight as well (169–171).  Mothers are at an increased risk 
of 3rd and 4th degree lacerations when delivering macrosomic infants (169).  Mothers who undergo 
vaginal births after caesarean delivery are also at increased risk of 3rd and 4th degree lacerations (172). 
Anal sphincter tears were found to be more likely in nulliparous women delivering macrosomic infants 
(OR = 3.8, 95%CI: 2.4-6) (173). 
Mothers are at increased risk of undergoing a caesarean delivery when delivering a macrosomic 
infant (26), as compared to a normal weight infant.  However it is important to note that poor diagnostic 
accuracy of macrosomia prior to delivery are also related to adverse outcomes more so than actual infant 
birthweight (174–176).    
 
2.3.8 Insufficient Fetal Growth 
Insufficient fetal growth can occur due to a variety of factors. This section will discuss 
Intrauterine Growth Restriction (IUGR), and outline common determinants of insufficient growth, as well 
as related fetal outcomes.  Insufficient growth is commonly linked to perinatal morbidity and mortality.   
 
2.3.8.1 Intrauterine Growth Restriction and Insufficient Growth  
Intrauterine Growth Restriction (IUGR) is a concerning sub-class of poor growth in fetuses. 
IUGR is a clinical diagnosis which is not simply based on the smallness of the fetus but on the 
pathological reasons for decreased fetal growth.  At present, there is no consensus as to the exact 
definition of IUGR. It has been defined as “fetal growth less than normal for the population and growth 





fetus” (178) whereas the American College of Obstetricians and Gynecologists define it as “fetuses with 
an estimated fetal weight that is less than the 10th percentile for gestational age” (179).   
IUGR is estimated to occur in approximately 3 to 7% of all pregnancies (180). These infants are 
at risk for further complications (poor birth and survival outcomes) as compared to infants that are SGA 
without IUGR(181).    
It is important to note that not all SGA babies will be classified as IUGR, and not all babies 
classified as IUGR will be SGA. The classification SGA can and does include healthy (but small) babies, 
whereas babies diagnosed as IUGR are not necessarily as healthy as possible.  
Gardosi (2009) (182), identifies an interesting population of babies born relatively small to their 
larger mothers, who are considered SGA only when using customized population centiles. Babies that 
only are SGA by population standards, and are not considered SGA under customized centiles are not at 
higher risk for any adverse perinatal outcomes (OR:1.9, 95%CI: 0.3-13.9), and are most likely “small-
normal” babies which have not experienced any pathological conditions in utero. Compared to babies that 
are SGA by population centiles (OR: 4.0, 95% CI: 2.3-7.1), babies that can only be identified as SGA on 
customized centiles are at higher risk (OR: 10.8, 95%CI: 5.6-20.8) of adverse outcomes.  
Factors leading to IUGR can be similar to those leading to insufficient growth, and include (50): 
Poor maternal health – i.e. cardiac disease, hypertension, renal disease, low SES, smoking, drug and 
alcohol use, poor nutrition, placental insufficiency, multiple births (further discussed in section 2.3.4), 
mutations in IGF-I (insulin-like growth factor -I) gene, chromosomal abnormalities, congenital infections 
(i.e. cytomegalovirus, rubella, syphilis, toxoplasmosis) and teratogens (50).  Placental insufficiency can 
lead to IUGR (155), directly and indirectly via pregnancy induced hypertension (183–186) which in turn 
leads to IUGR. 
 
Symmetry vs. Asymmetry in IUGR 
Similar to overgrown fetuses, undergrown fetuses can also exhibit either symmetrical or 
asymmetrical growth patterns.  Symmetrical growth restriction occurs in the first and second trimesters of 
growth, and leads to the entire fetal body proportionally being growth restricted (global restriction) (187). 
Symmetric growth restriction occurs in approximately 20-30% of all IUGR infants (188).  Asymmetrical 
growth restriction, on the other hand, is hypothesized to be protective towards head and brain growth 
(189), leading to the abdomen being smaller relative to the head. This pattern of growth occurs in the third 





pattern (187).  A 1991 study (188) of growth restriction found that the timing of the risk factor (causing 
growth restriction) interacting with the fetus was more important in determining whether growth 
restriction would be symmetrical or asymmetrical, rather than the specific risk factor. A 1989 paper 
suggested that symmetric growth restriction is likely to be a consistent growth restriction, whereas 
asymmetric growth restriction is likely to occur as a result of slowing growth rates towards the end of the 
pregnancy (68).  They also determined that symmetric growth restricted pregnancies resulted in more 
preterm deliveries than asymmetric ones, and that symmetrically growth restricted infants born at term 
had a lower mean birth weight than their asymmetric term counterparts. As with asymmetric growth in 
macrosomic infants, some authors question the clinical utility of investigating fetal growth symmetry 
(167) and studies have failed to show a difference in outcomes between symmetrically and 
asymmetrically grown infants (190–193).   
 
2.3.8.2 Determinants of Insufficient Growth 
There are many established risk factors known to influence fetal growth. These factors can be 
classified as maternal, fetal and placental factors (2). Maternal factors include: maternal age, low pre-
pregnancy weight and BMI, low gestational weight gain, mother being SGA at birth, multiple gestation, 
parity, low interpregnancy interval, maternal illnesses such as: hypertension, diabetes, autoimmune 
disorders, drug and alcohol use, teratogen exposure and smoking.  Fetal factors include: genetic 
conditions, congenital abnormalities and congenital infections contracted by the mother.  Placental factors 
include: pre-eclampsia, placenta previa, vasa previa, velamentous cord insertion, and uterine and placental 
abnormalities. 
 
Maternal Factors  
Maternal Age 
Maternal age plays a role in determining fetal growth, with teenage pregnancies at high risk of 
SGA births (194), however, this effect may be due to lower socioeconomic status within the age group 
(195). Maternal age is closely tied to maternal pre-pregnancy weight and BMI, especially in the case of 
adolescent mothers, who may still be growing.  The factor of extremely young age is likely an indirect 
factor affecting birth weights (4). Likewise, older maternal age likely affects birth weight indirectly via 
age related risk factors.  A 2016 Finnish population study found that being ≥ 40 years was associated with 
a 2.2 percent increase in the probability of giving birth to a low birth weight infant (196). Older maternal 





Low Pre-Pregnancy Weight/BMI 
A 2011 systematic review and meta-analysis found that the risk of low birth weight (RR: 1.64, 
95%CI: 1.38-1.94) was increased in mothers with underweight BMI. This effect holds in both developing, 
and developed countries. Underweight women are also at increased risk of giving birth to an infant with 
IUGR (RR: 1.54, 95%CI; 1.38-1.72) (199). Mothers’ pre-pregnancy BMI has been found to be a strong 
predictor of low birth weight in Japanese populations, with underweight mothers at higher risk of 
delivering a low birth weight infant as compared to mothers with ‘normal’ BMI (OR: 1.86, 95%CI: 1.04-
3.31) (200), and similar findings were reported in a 2010 study as well (201).  Socioeconomic status may 
play a role in this association (4,202,203). Maternal pre-pregnancy BMI and gestational weight gain are 
highly related factors in determining infant birth weight and size for gestational age.   
Maternal obesity has been linked to lower birth weight and small size for gestational age in 
numerous studies. One explanation for the phenomenon of low birth weight infants being born to mothers 
with higher BMIs is the increased rates of preterm birth with increasing maternal BMI.  Factors such as 
increased risks of pre-eclampsia (204–206) with increasing maternal obesity contribute to increased rates 
of preterm births.  Multiple studies have associated maternal obesity and low birth weight with increased 
rates of preterm births.  A 2010 systematic review and meta-analysis suggested that the incidence of low 
birth weight (<2500g) in mothers with higher BMIs may be complicated by the effect of increased rates 
of pre-term birth in these mothers, finding that overweight and obese mothers had an increased risk of 
giving birth to a very low birth weight (<1500g, RR: 1.61, 95%CI: 1.42-1.82) or extremely low birth 
weight infant (<1000g, RR: 1.31, 95%CI: 1.08-1.59). They also found that risks of giving birth to an 
extremely low birth weight infant (<1000g) increased with increasing maternal BMI; with overweight 
mothers’ RR: 1.18, (95%CI: 0.94-1.47), obese mothers’ RR: 1.43, (95%CI: 1.05-1.95), and very obese 
women RR: 1.98, (95%CI: 1.36-2.89) (207).  These authors suggest that higher maternal BMI is not a 
protective factor against low infant birth weight (207).  A 2018 retrospective cohort study based in 
Hawaii found that the odds of preterm birth were increased with increased maternal BMI (BMI>30.0), as 
compared to normal weight women (aOR: 1.24, 95%CI: 1.06-1.45).  These risks were increased in Native 
Hawaiian and Pacific Islander mothers as compared to white mothers. These authors speculate that 
increases in preterm deliveries can potentially contribute to increases in low birthweight (208). A 1992- 
2010 Swedish cohort study found that odds of extremely preterm deliveries increased with increasing 
maternal BMI (209), with BMI 25-30: (OR: 1.26, 95%CI: 1.15-1.37), BMI 30-35: (OR:1.58, 95%CI: 
1.39-1.79), BMI 35-40: (OR: 2.01, 95%CI: 1.66-2.45),  and BMI greater than 40: (OR: 2.99, 95%CI: 
2.28-3.92) (209). Additionally, some studies have found a link between maternal obesity and growth 





demonstrated a higher incidence of IUGR as compared to offspring of normal BMI mothers (210). 
Numerous other studies support this association (7-12).  
Induced early births also contribute to the rates of low birth weight infants born to mothers with 
increased BMI. A 2010 systematic review found that the risk of an induced preterm birth increased with 
increased BMI, with overweight women having a relative risk of: 1.15, (95%CI:1.04-1.27), obese women 
having a relative risk of: 1.56, (95%CI: 1.42-1.71) and very obese women having a relative risk of: 1.71, 
(95%CI: 1.50-1.94) ((preterm defined as birth <37 weeks, 32-36 weeks) this effect was not present when 
looking at overall preterm births) (207). A 2015 study using data from the Prospective Observational Trial 
to Optimize Pediatric Health Study (PORTO) found that obese mothers were more likely to deliver early 
via both planned and emergency Caesarean delivery, leading to lower birth weights, as compared to 
mothers with normal BMI (212).The 2005 Preterm Prediction study found that pre-pregnancy obesity is 
associated with lower rates of spontaneous preterm births as compared to normal weight pre-pregnancy.  
Authors do note that increased rates of medically indicated preterm births in mothers with higher BMIs 
may be in part due to increased rates of pre-eclampsia (213). 
Other factors likely to contribute to SGA and growth restricted births in mothers  with higher 
BMI include differences in gestational weight gain (214–218), and bariatric surgeries (219–221).  It is 
important to note that some studies have reported no association between increasing maternal BMI and 
insufficient fetal growth (222). 
 
Low Gestational Weight Gain  
Suboptimal maternal gestational weight gain has been linked to lower birth weight in infants 
(84,88).  A 2009 systematic review of current gestational weight gain guidelines determined that strong 
evidence exists for the association between poor gestational weight gain, and lower birthweight 
(regardless of how gestational weight gain was measured –i.e. rate vs. total).  The systematic review also 
determined that a strong association exists between gestational weight gain below the guidelines, and 
birthweights under 2500g, specifically in normal weight and underweight mothers. Being born SGA was 
also found to be associated with maternal gestational weight gain below Institute of Medicine guidelines. 
(89).  Lower income mothers are at increased risk for both insufficient and excess gestational weight gain 
(93,94). 
Mothers SGA at Birth 
A mother that is born SGA herself is 2.5-2.7 times more likely to go on to give birth to a baby 






Growth patterns in utero can vary when a mother is carrying multiples, as compared to a 
singleton pregnancy (224). This is discussed further in section 2.4 of this thesis.  
 
Parity and Inter-Pregnancy Interval 
High parity and short inter-pregnancy intervals can be linked to insufficient growth; these factors 
may be tied to low socioeconomic status (80) as well as age (4).  A 2013 study found that nulliparous 
women younger than 18 years demonstrated the highest odds (pooled, adjusted OR: 1.80) of giving birth 
to a SGA infant as compared to mothers aged 18-35 that are multiparous (having parity 1-2) (225).  A 
recently published Spanish birthweight for gestational age chart customized for parity and delivery type 
reported that birthweights were lower in primiparous mothers as compared to in multiparous 
women(226).   
 
Hypertensive Disorders 
Hypertensive disorders include gestational and chronic hypertension, pre-eclampsia, and 
eclampsia.  Hypertensive disorders are estimated to affect 7% of all Canadian pregnancies (227,228). 
Hypertension is hypothesized to contribute to insufficient growth by decreasing the rate of utero-
placental blood flow (229–231). Both mild and severe forms of maternal hypertension has been found to 
be associated with lower birth weights (232). 
Maternal hypertension has been found to vary across ethnicities (101,233–235).  A 2006 study 
found that having chronic hypertension was associated with giving birth to a low birth weight infant in 
both Haitian (OR: 6.8, 95%CI: 4.3-10.6) and African American (OR: 2.9, 95%CI: 2.1-4.0) women (236). 
One study found that gestational hypertension can be associated with concurrent carbohydrate intolerance 
(237).  Data from the Public Health Agency of Canada Perinatal Surveillance System data have also 
reported that rates of gestational hypertension can vary with maternal age- with older mothers 
experiencing increased rates of gestational hypertension (238). Factors increasing the risk of maternal 
hypertension include multiple gestation, and parity, whereas factors decreasing the risk of hypertension 
include smoking. (239).   
Evidence exists to suggest that hypertension has different effects in singleton and twin 





A 2013 study reported that chronic hypertension was more likely to progress to pre-eclampsia/eclampsia 
in twin pregnancies, as compared to in singleton pregnancies.  Twins of hypertensive pregnancies were 
also delivered at earlier gestational ages than singletons of hypertensive mothers (242). Authors of a 2015 
study comparing hypertensive versus ‘normotensive’ twin pregnancies found that birth weights and 
frequencies of SGA births were comparable in the groups, suggesting that maternal gestational 
hypertension during a twin pregnancy may not necessarily detract from growth in utero (243).  
Pre-eclampsia is related to low birth weight and SGA infants (244,245), and has also been 
associated with IUGR in singleton births (246).  Pre-eclampsia was found in one Canadian population to 
have an association with babies born as severe (<3rd percentile size for gestational age) SGA at term (OR: 
4.6, 95%CI: 1.6-13.2) (247).  In pre-eclamptic pregnancies, babies born preterm are more likely to have 
experienced insufficient growth, and babies born at term exhibited similar growth to babies of mothers 
without pre-eclampsia. Authors of this study suggest that gestational age plays a key role in determining 
birth weight in pregnancies complicated by pre-eclampsia (231).  Other studies support the role of 
gestational age in affecting the outcome of pre-eclamptic pregnancies (229,230).  Evidence exists to 
suggest that pre-eclampsia is also more common in twin pregnancies than in singleton pregnancies 
(241,248,249). However, authors of a 2014 study suggested that pre-eclampsia and IUGR are not 
correlated in twin gestations (248).  
 
Gestational Diabetes and Hypoglycemia  
Maternal pre-existing and gestational diabetes can be linked to decreased fetal growth (250), in 
part by  affecting normal placental function (251), as well as fetal and placental vascular development 
(252). The fetal insulin hypothesis can also explain the link between a diabetic uterine environment and 
low birth weight (253). In this theory, a genetically predisposed resistance to insulin in the fetus, along 
with other genetic factors, are thought to contribute to the decrease in ‘insulin-mediated growth’. Changes 
in fetal or maternal insulin secretion, resistance, or glucose sensing can also contribute to altered 
growth(253).  
Maternal hypoglycemia has been found to lead to low birth weights in infants, as compared to 









Tobacco use is amongst one of the most well established risk factors for insufficient fetal growth 
(4).  Smoking during pregnancy has been found to increase the risk of growth restriction by 2 to 3 times 
(4). Another study also found maternal smoking to be linked to an up to 250g discrepancy in birth weight 
(182,257).  Maternal smoking was to have an association (OR: 5.3, 95%CI: 2.4-11.7) with being severely 
SGA (<3rd percentile size for gestational age) births at term in a Canadian population (247).  Smoking 
more than half a pack of cigarettes per day was found to be associated with greater risks of premature 
delivery (OR:1.2, 95%CI: 1-1.44), IUGR (OR:2.02, 95%CI: 1.67-2.43) and low birth weight (OR: 2.00, 
95%CI: 1.56-2.57) in a 2005 United States study (258).  The association between tobacco exposure and 
decreased birth weight has been shown in numerous studies (4,259–264). Second hand smoking has also 
been found to have an effect on fetal birth weight(262,265–267). Furthermore, Gestational smoking has 
also been linked to preterm births in many studies (268–270).  
 
Alcohol Use  
Maternal alcohol use is associated with insufficient growth.  The effect of alcohol will vary 
between early and late stages of pregnancy, with late stage alcohol consumption having stronger effects 
on birth weight(4). This does not, however, imply that early pregnancy drinking has no effect.  Heavy 
alcohol use was also found to increase the risk of IUGR (OR: 1.35, 95%CI: 1.03 – 1.76) and low birth 
weight (OR: 1.57, 95%CI: 1.12-2.22) (258). The use of alcohol has been linked to concurrent use of 
tobacco  (271). Concurrent alcohol and tobacco use was found to increase rates of preterm births in a 
2006 study (270). Alcohol use has also been linked to socioeconomic status (272), and obesity(273).  
 
Drug Use 
A 2005 United States study found that cocaine use increased the risk of premature delivery (OR: 
1.25, 95%CI: 1.01-1.55), IUGR (OR 2.24, 95%CI: 1.72-2.91), and low birth weight (OR: 3.59, 95%CI: 
2.38-5.42)(258). 
Mothers who use report drug use during pregnancy are more likely to be younger, have lower 
educational attainment, lower household income, and are more likely to have also used tobacco and 
alcohol (274).  Maternal use of tobacco and cocaine are associated with decreased birth weight as 





Marijuana exposure in utero has also been linked to insufficient growth. A 2015 study in a 
population with legalized access to marijuana found that mothers who self-reported marijuana use were 
50% more likely to give birth to an infant with low birth weight (OR:1.5, 95%CI: 1.1-2.1; p=0.2), 
controlling for concurrent tobacco use, maternal age, race and ethnicity. Being born SGA was not 
associated with marijuana exposure (276). A 2016 Australian study found that marijuana use at 20 weeks 
gestation was linked to preterm birth (277). Numerous other studies have explored the effects of 
marijuana use on fetal growth related outcomes (278–281).  
Prescription drug usage during pregnancy can also affect fetal growth.  A 2012 meta-analysis 
found that maternal gestational antidepressant use is significantly associated with low birth weight (RR: 
1.44, 95%CI: 1.21-1.70), and this association holds, regardless of type of antidepressant being used (282). 
Kuczkowski (2007) has a comprehensive overview of how various illicit drugs interact with a 
pregnancy (283). Drug use during pregnancy is difficult to ascertain due to increased stigma, and fear of 
repercussions. Preterm birth can also confound the relationship between gestational drug use and 
decreased fetal growth (261,283). 
 
Fetal Factors    
Congenital Abnormalities 
A majority of congenital defects have concurrent insufficient growth, usually diagnosed as IUGR. 
Khoury et al., in 1988 found that 22.3% of infants born with congenital abnormalities were also IUGR 
(relative risk of 2.6) (with IUGR classified in this study as birth weight below the 10th percentile for 
gestational age, race and sex).  The relative risk of for infants with trisomy 18 of being IUGR was 46 
(95%CI: 20.6-104.0), trisomy 13 has a relative risk of 9.5 (95%CI: 5.0-18.1), and a relative risk of 24.7 
(95%CI: 18.2-33.6) was reported for infants with anencephaly being IUGR.  The authors suggest three 
hypotheses explaining the association between congenital abnormalities and insufficient growth; a) 
insufficient growth predisposes the fetus to congenital abnormalities, b) congenital abnormalities are the 
cause of insufficient growth, or c) congenital abnormalities and growth restriction coexist due to some 
other factor(284).  An Atlanta population based study found that there is a significant association between 
birth defects and insufficient growth, and that there is excess morbidity in the low birth weight 
population, in part attributable to birth defects (285). It is important to note that increased premature 







A wide variety of congenital infections such as cytomegalovirus, rubella, syphilis, hepatitis and 
toxoplasmosis can be contracted by the mother during pregnancy that have the potential to lead to 
insufficient fetal growth (286,287). 
 
Premature Delivery  
Insufficient growth is strongly linked to prematurity at birth.  Premature births can be, but are not 
necessarily always due to a pathological concern.  It is important to note that iatrogenic premature births 
have increased, due to increased rates of obstetric interventions such as caesarean delivery, and induction 
of labour, in what Louis and Platt (2011) (288) call the ‘paradox of modern obstetrics’. This has gone on 
to cause a “left shift” in the population distribution of gestational age at birth (289). Despite this, evidence 
does exist to suggest that preterm births are associated with decreased growth, amongst other adverse 
outcomes. Threatened preterm labour was found to be associated (OR: 3.9, 95%CI: 1.3-11.4) with severe 
SGA births in a Canadian population (247). Preterm birth has been found to be linked to fetal growth 
restriction in numerous studies (37–39). Previous preterm birth has also been associated with subsequent 
preterm birth and low birth weight infants (91,290).  Using the size for gestational age measure, which 
incorporates both weight and gestational age at birth allows for a better assessment of the role of 
premature delivery on insufficient growth (291). 
 
Placental Factors 
Placental factors include: pre-eclampsia, placenta previa, and vasa previa. Other placental factors 
include velamentous cord insertion, and uterine and placental abnormalities. Poor maternal arterial 
development (leading to decreased placental blood flow) has also been found to lead to insufficient fetal 
growth (140).  Decreased rates of placental growth factor and insulin-like growth factor have been 
associated with insufficient fetal growth (142,292,293).  Note that some of these factors have also been 
found to have an influence on multiple births as well (further explored in section 2.3.4). 
 
Placenta Previa and Vasa Previa  
Both placenta and vasa praevias and placenta accreta  may contribute to the effect of low birth 
weight by way of preterm birth –infants affected by these conditions may be more likely to be born early 





found that mothers diagnosed with placenta previa were at increased odds of having a preterm delivery 
from 20- 23 weeks (OR: 1.81, 95%CI: 1.24-2.63), from 24-27 weeks (OR: 2.90, 95%CI: 2.46-3.42) and 
subsequent smaller sized infants (OR: 1.24, 95%CI: 1.17-1.32) (297).  However, a 1991 hospital based 
study concluded that placenta previa does not contribute to SGA, with authors suggesting that 
conservative clinical management may have played a role in this (299).  A 2010 retrospective cohort 
study found no association between placenta previa and decreased size for gestational age, however, this 
study did not explore preterm delivery (300).  Lastly, a 2015 systematic review and meta-analysis paper 
found that increased risks of preterm delivery exist for women diagnosed with placenta previa (RR: 5.32, 
95%CI: 4.39-6.45), vasa previa (RR:3.36, 95%CI: 2.76-4.09) and velamentous cord insertions (RR: 1.95, 
95%CI: 1.67-2.28) (301). 
 
2.3.8.3 Outcomes of Insufficient Growth  
 
IUGR and overall insufficient growth lead to increased risks of immediate and later life adverse 
events (302). ‘Immediate’ events include congenital abnormalities, neurological problems, hypocalcemia, 
hypoglycemia, meconium aspiration, respiratory distress syndrome (303), cerebral palsy, polycythemia 
and hyperbilirubinemia (2). Later life (long term) events caused by IUGR are primarily metabolic, and 
include later life obesity, cardiovascular disease, type 2 diabetes, hypertension and hypercholesterolemia 
(303). 
 
Fetal Short Term Outcomes  
Short term outcomes of insufficient fetal growth include congenital abnormalities, 
neurodevelopmental problems, differential body composition, hypocalcemia and hypoglycemia. 
Respiratory distress syndrome, perinatal asphyxia, polycythemia, polyhydramnios and hyperbilirubinemia 
are other acute outcomes of insufficient growth. Stillbirth is another cause of concern associated with 
insufficient growth (62,144). It is important to note that these outcomes are also strongly associated with 
preterm birth.  
 
Neurological problems  
Low birth weight infants have higher rates of neurological problems.  This may be due to clinical 





survival of these infants. (304,305). Perinatal infections such as necrotizing enterocolitis and meningitis, 
have also been linked to poor neurodevelopmental outcomes in low birth weight and extremely low birth 
weight infants (306). Rates of cerebral palsy have been found to be 4 to 6 times higher (in live births from 
32-42 weeks gestation) in babies below the 10th percentile for size for gestational age (compared to births 
between the 25th to 75th percentiles) (2,161,307). A 2013 paper also reported that higher rates of spastic 
unilateral cerebral palsy was associated with insufficient intrauterine growth, and low birth weights, 
length, and head circumference (162). Increased rates of premature births in this population also 
contributes to this association (308).  
 
Body Composition and Hormonal Status  
Fetal body composition can be compromised by suboptimal growth. Growth restriction occurs 
due to the fetus undergoing “adaptive changes in metabolism” as a developmental response to poor 
uterine conditions (309). This leads to decreases in body fat percentage, total fat composition and lean 
mass in the growth restricted infant, as compared to an average grown infant. These changes are 
associated with decreased cord insulin and IGF-1 (insulin-like growth factor 1) levels, factors which can 
be affected by available maternal nutrient supply.   
 
Hypocalcaemia 
Hypocalcaemia and hypoglycemia are associated with insufficient growth in infants. 
Hypocalcaemia has been linked to low birth weight infants, however, this outcome may be linked to 
prematurity at birth as well (177,310). SGA infants experience higher rates of hypoglycemia as compared 
to matched average for gestational age infants (311).  Hypoglycemia due to IUGR has also been linked to 
poor neurodevelopmental outcomes (312).  
 
Fetal Long Term Outcomes  
Long term outcomes of insufficient growth include type 2 diabetes, decreased adult functionality, 
hypertension, hypercholesterolemia, diabetes mellitus, blood pressure abnormalities, cardiovascular 







Type 2 Diabetes  
Type 2 diabetes may have early life origins due to insufficient growth conditions. Insulin 
resistance developing as a result of insufficient growth and suboptimal growth environment can 
contribute to the development of later life type 2 diabetes (309). This association has been shown in 
multiple studies (320–323). 
 
Maternal Long Term Outcomes  
Maternal long term outcomes also exist, and include later life coronary heart disease, increased 
risk of subsequent SGA pregnancies, later life obesity, and cardiovascular disease. One long term 
outcome affecting mothers who give birth to undergrown fetuses is an increased risk of later coronary 
heart disease (2,324,325). Mothers who give birth to low birth weight infants can also be at increased risk 
of developing later life obesity or later life cardiovascular disease, however, this is likely due to 
underlying conditions (i.e. socioeconomic status) contributing to the adverse health outcomes of both 
mother and child (2). Mothers who give birth to SGA singletons were found to be at increased risk of 
SGA in subsequent twin pregnancies (326).  
 
2.3.9 Trends Over Time  
SGA births have been decreasing, and LGA births have been increasing (2). This trend has been 
observed in  Sweden(327), Canada (32), the United States (148), China (328), Germany (329), 
Scotland(330), and Denmark (331). The LGA increase can be attributed in part to increases in maternal 
pre-pregnancy weight and BMI, increased gestational weight gain and decreased maternal smoking. The 
SGA decrease can be attributed to increasing maternal age, and increased rates of diabetes and 
hypertension; trends recently studied in the Canadian and American populations(332).  It is important to 
note, however, that increases in caesarean deliveries and labour induction (2,21) have led to earlier 
deliveries, leading to an impact on population level size for gestational age measurements. As discussed 
earlier, iatrogenic premature births have increased, due to increased rates of obstetric interventions such 
as caesarean delivery, and induction of labour, in what Louis and Platt (2011) (288) call the ‘paradox of 








2.3.10 Fetal Growth – Gaps in Knowledge  
Most studies focus on the outcomes of being SGA or having low birth weight. Only recently have 
studies begun to focus on the excessively grown babies, as they are able to survive, however, they are still 
at risk of later life adverse outcomes. Babies born small relative to their larger mothers (182) are an 
understudied population, as it is difficult to determine the cause of smaller size at birth than anticipated.  
There is no consensus on how to determine optimal fetal growth trajectories, whether an optimal growth 
trajectory even exists, or if it is clinically necessary (45).  At present, because fetal growth in utero is 
highly inaccessible, it is difficult to know with certainty which factor comes first (i.e. does insufficient 
growth cause an abnormality, or does the abnormality lead to insufficient growth?), making it difficult to 
determine causality.  
Fetal growth is well studied in singletons, however, less research is available for multiples. The 
accurate study of fetal growth is further complicated by the fact that the fetus is highly inaccessible in 
utero.  Methods such as ultrasound can have poor accuracy in determining anthropometric measurements 
and estimated weights (176,333,334).   
 
2.3.11 Fetal Growth – Conclusions  
Understanding normal fetal growth allows us to better understand patterns of abnormal fetal 
growth.  Overgrown and undergrown fetuses are both at increased risk of perinatal morbidities and 
mortality as compared to ‘optimally’ grown babies.   
 
2.4 Maternal Obesity  
 
2.4.1 Introduction  
Maternal obesity is a rapidly increasing cause for clinical concern.  Increasing maternal BMI 
leads to increases in adverse outcomes for both mother and child, some of which are long-lasting.  Rates 
of obesity in adult Canadian women have increased from 14.5% in 2003 to 18.7% in 2014(335).  The 
combined rate of overweight and obesity in women was 46.2%, or approximately 6.1 million women in 
Canada in 2014(335). According to the Public Health Agency of Canada Maternity Experiences Survey 
(2006), 13.3% of women of reproductive age were obese pre-pregnancy, and 48.8% of women had excess 





Fetal growth is determined by 4 key factors: maternal, fetal, and placental health, and their effect 
on predestined growth potential (47).  Maternal lifestyle can play a key role in affecting fetal size (338). 
Looking at infant size for gestational age, the number of infants being born SGA has decreased, 
and the number of infants born LGA has increased, due in part to societal changes in maternal BMI and 
behavior(2).  This section will outline how maternal obesity affects the pregnancy and fetal growth.  
 
2.4.2 Maternal Obesity and Adverse Events in Singletons  
Increases in obesity, and maternal obesity, bring with them increases in the risk of maternal 
obesity related adverse events.  The Pedersen Hypothesis, shown in Figure 2.1 outlines one biological 
mechanism by which increased energy transfer from mother to child can lead to excess fetal growth. 
Numerous studies have established the detrimental effects of maternal obesity on maternal-fetal 
health(13–16). Additionally, maternal obesity can lead to later life adverse events for infants (339). These 
adverse events can be categorized into maternal, fetal, and delivery events.  
 
2.4.2.1 Adverse Maternal Events  
Adverse maternal events include gestational hypertension, gestational diabetes, preeclampsia, as 
well as postpartum complications, such as hemorrhage, thrombosis, infection, and placenta previa (14). A 
2004 study of over 16,000 births concluded that obese women (BMI 30-34.9) were 2.5 times more likely 
(95%CI: 2.1-3.0) to develop gestational hypertension, and 1.6 times more likely to develop pre-eclampsia 
(95%CI:1.1-2.2) and that morbidly obese women (BMI>35) are 3.2 times more likely (95%CI: 2.6-4.0) to 
develop gestational hypertension, and 3.3 times more likely (95%CI: 2.4-4.5) to develop preeclampsia as 
compared to women with a normal BMI (340). The same study found that obese women had an odds ratio 
of 2.6 (95%CI: 2.1-3.4) of developing gestational diabetes, and this OR increases to 4.0 (95%CI; 3.1-5.2) 
in morbidly obese women. (340). These results of increasing likelihood of maternal complications with 
increasing BMI have been replicated in numerous studies (13,16,341–343).   
 
2.4.2.2  Adverse Fetal Events 
Adverse fetal/neonatal events include stillbirth, intrauterine growth restriction, birth traumas, fetal 
macrosomia, and fetal malformations/congenital anomalies such as neural tube defects, spina bifida, 
cardiovascular anomalies, cleft lip and palate, low APGAR scores, anorectal atresia and hydrocephaly 





a stillbirth is 2.07 (95%CI:1.59-2.74) as compared to women with normal BMI (345), and further studies 
have confirmed an effect of increasing risk of stillbirth with increasing maternal obesity (346,347). In 
morbidly obese women (BMI >40), one study found the adjusted odds ratio of stillbirth to be 2.79 (1.94-
4.02) (14).  One study found that obese women are 1.7 times more likely (95%CI: 1.4-2.0) to deliver a 
macrosomic infant (birth weight >4000g), and this likelihood increases to 2.0 times more (95%CI: 1.5-
2.3) for morbidly obese women, as compared to a control of women with normal BMI. The odds of 
delivering a macrosomic infant weighing greater than 4500g is further increased; obese women are 2.0 
times more likely (95%CI:1.4-3.0) and morbidly obese women are 2.4 times more likely (95%CI: 1.5-3.8) 
as compared to women with normal BMI (340). Morbidly obese women are also at greater risk of 
delivering an LGA infant with an odds ratio of 3.82 (95%CI: 3.50-4.16) (14).  A 2008 meta-analysis 
studying neural tube defects (NTD) found that obese women have an odds ratio of 1.70 (95%CI: 1.34-
2.15) of NTDs and severely obese women demonstrate an odds ratio of 3.11 (95%CI: 1.75-5.46) of giving 
birth to an infant with a neural tube defect, as compared to women with normal BMI (348). Lastly, a 
comprehensive systematic review and meta analysis from 2009 concluded the following odds ratios for 
the risk of congenital anomalies in infants born to obese mothers: neural tube defects 1.87 (95%CI: 1.62-
2.15); spina bifida 2.24 (95%CI: 1.86-2.69); cardiovascular anomalies 1.30 (95%CI: 1.12-1.51); cleft lip 
and palate 1.20 (95%CI:1.03-1.40); anorectal atresia 1.48 (95%CI: 1.12-1.97); and hydrocephaly 1.68 
(95%CI: 1.19-2.36) (349).  Infants of mothers with higher BMIs are at significant risk of many adverse 
health outcomes.  
 
2.4.2.3 Adverse Birth and Delivery Events  
Adverse birth and delivery events include shoulder dystocia, increased rates of caesarean birth, 
preterm delivery, and other birth traumas (such as operative vaginal delivery which can lead to increased 
risk of maternal and fetal mortality (344). A 2004 study by Weiss et al. found that morbidly obese women 
(BMI>35) had an odds ratio of 1.5 (95%CI 1.1-2.1) of giving birth to a preterm infant, as compared to 
women with normal BMI; (obese women demonstrated a similar propensity towards preterm birth as 
normal BMI women) (340). Other studies have also replicated this effect of increased rates of preterm 
births in morbidly obese women (213).  A 2008 meta-analysis of pregnancy outcomes found the risk of 
shoulder dystocia to be 1.04 (95%CI: 0.97 – 1.13) for obese women, as compared to women with normal 
BMI (350). In morbidly obese women (BMI >40), the risk of shoulder dystocia (increases to) was 3.14 
(95% CI: 1.86-5.31) compared to women with normal weight (BMI 19.8-26). (14). A multicenter 
prospective study found that rates of caesarean delivery increased with increasing maternal BMI. The 





to 3.0 (95%CI: 2.2-4.0) for morbidly obese women (BMI >40), as compared to women with normal BMI 
(BMI < 30).  Caesarean rates were 20.7% for normal BMI women (3752 patients, BMI < 30), 33.8% in 
obese women (1473 patients, BMI 30-34.9) and 47.4% in morbidly obese women (877 patients, BMI 
>35) (340). In morbidly obese women (BMI>40), one study found that the risk of a Caesarean delivery 
increased to 2.69 (2.49-2.90) as compared to women with normal weight (BMI 19.8-26) (14). 
This section has explored the increasing risks of the aforementioned adverse events for both 
mother and child with maternal obesity. These effects are well studied in singleton, nulliparous, low risk 
births. Research is still lacking that describes how these adverse events translate to a twin pregnancy.  The 
next section will outline what is known about adverse events specifically in twin pregnancies further 
complicated by maternal obesity.  
 
2.4.3 Maternal Obesity and Adverse Events in Twins  
Adverse events in singletons of obese mothers are well studied. Relevant studies exploring the 
aforementioned outcomes in twins born to obese mothers are not as well explored. The literature on this 
topic is divided; some studies have found evidence of an effect of obesity as a risk factor for adverse 
events in twin pregnancies, whereas others have not. Again, these adverse events can be categorized into 
maternal, fetal and delivery events. Risks for the following outcomes are generally increased for twins, as 
compared to singletons.  
 
2.4.3.1 Adverse Maternal Events 
Maternal adverse events include gestational hypertension, preeclampsia and gestational diabetes. 
A 2013 study comparing adverse outcomes in twin pregnancies across maternal BMI categories 
determined that obesity was associated with increases in maternal adverse events (351) . This study found 
that obese (BMI>30) mothers of twins are 2.37 times (95%CI: 1.20 – 4.68, p=0.011) more likely than 
normal weight (BMI: 18.5-24.99) mothers of twins to develop gestational hypertension, 2.23 times 
(95%CI: 1.07-4.62, p=0.028) more likely to develop preeclampsia, and 5.82 times (95%CI: 2.46 – 13.81, 
p<0.001) more likely to develop gestational diabetes. These results were replicated in a 2013 study in a 








2.4.3.2 Adverse Fetal Events 
Fetal adverse events include intrauterine growth restriction, fetal macrosomia, small size for 
gestational age and stillbirth.  A 2011 study of 313 twin births in New York found that maternal obesity 
(BMI>30) was not a contributing risk factor to intrauterine growth restriction in twins (354).  This study 
defined IUGR as either twin with birth weight below the 10th percentile for gestational age.  A 2013 study 
of adverse events in twin pregnancies reported only one case of fetal macrosomia out of 514 included 
births  (351). Maternal pre-gravid BMI was found to be an insignificant risk factor towards SGA 
designation in twins in a 2010 Japanese study of dichorionic twins (355). In twin pregnancies, obesity 
was found to lead to a 31% greater chance of stillbirth as compared to mothers with normal BMI (OR: 
1.31, 95%CI: 1.02 -1.68).  This effect was only found to be significant for class I obese mothers (356).  
 
2.4.3.3 Adverse Delivery Events  
Delivery events include caesarian delivery, preterm delivery and shoulder dystocia. A 2014 study 
in a Canadian population reported that increased maternal obesity was associated with an increased risk of 
Caesarian delivery (OR: 2.2, 95%CI: 1.2-4.1)(357). A 2008 study from Missouri determined that obese 
women (BMI>30) delivering twins were at a lower risk (OR: 0.68, 95%CI: 0.62-0.75) of spontaneous 
preterm birth, as compared to obese women delivering singletons.  This association was seen in mothers 
who gained between 0.23 and 0.69 kg per week.  When looking at medically indicated preterm births of 
twins, obese women were at greater risk (OR: 1.37, 95%CI: 1.24-1.52) than non-obese women.  This risk 
increases with increasing BMI, with women of class III BMI at greater risk (OR: 1.64; 95%CI: 1.35-
2.01)(358).  
 
2.4.4 Maternal Obesity – Gaps in Knowledge  
While it may be intuitive to assume that the effects of maternal obesity leading to adverse events 
in singleton pregnancies would also translate to the same adverse events in twin pregnancies affected by 
maternal obesity, many prior studies do not verify this effect. The mechanisms leading to adverse events 
in twin pregnancies may not necessarily be the same mechanisms leading to adverse events in singleton 
pregnancies.  A 2000 study of dichorionic twin pregnancies found no association between increased 
maternal BMI and increasing pre-eclampsia in twins, however the association between BMI and pre-
eclampsia was present in singletons (359). A 2005 study of twin and singleton pregnancies in a high 
socioeconomic level population confirmed this; finding that maternal BMI was associated with increased 





differing results may be due to differences in populations studied.  Recently, a 2017 study found that 
maternal height (short (<159 cm) vs ‘normal’ (>160 cm)) may not be associated with gestational age or 
birth weight in twin pregnancies(361).  
Few data exist on mothers with extremely high BMI levels (i.e. >50).  No data currently exists 
exploring an association between maternal obesity and birth trauma in twins. The majority of studies 
exploring twin pregnancies and maternal obesity have focused on maternal outcomes- few studies have 
attempted to determine the combined effect of maternal obesity and multiple births.  It is unsure whether 
this gap exists due to a lack of an association, due to restrictions in sample size or is simply due to 
coincidence. Twin pregnancy is associated with higher risk of maternal complications (353) however, the 
contribution of maternal obesity to this risk in twin pregnancies is still unknown.   
 
2.4.5 Maternal Obesity – Conclusions 
Maternal obesity is increasingly becoming a cause for concern- due to the increased risks to both 
mother and child. These risks are further complicated in the case of multiple gestations. Further research 
is necessary to match the growing burden of obesity.  
 
2.5 Twin Births 
 
2.5.1 Introduction 
Twins and higher order multiple births require special obstetric consideration, because they are 
more complicated than the average singleton birth. These considerations usually lead to twins and other 
higher order multiple births being treated as exclusions in research. This section will outline the 
epidemiology of twin births, pathophysiology of the twin development process, and the different types of 
twins that can arise, and will explore how despite the added complications of studying twins, they are a 
relevant population for prenatal studies. 
 
2.5.2 Prevalence of Twins  
In 2011, 3.3% of all births in Canada were multiple births, a rate which has risen from 2.1% in 
1991(17).  This increase can be attributed in part to the increasing usage of artificial reproductive 
technologies (such as in vitro fertilization, frozen embryo transfer, and intracytoplasmic sperm injections) 





race, nutrition, and fecundity. Influence of these risk factors varies for monozygotic versus dizygotic 
pregnancies (366), and across different ethnic populations (367–371). 
In Canada, the multiple gestation rate was 20 per 1000 live births in 1991, 28.3 per 1000 live 
births in 2004, and rose to 31.4 per 1000 as of 2009 (372).  A similar change in rate of twin births can be 
observed in the United States; 23.1 per 1000 live births in 1991, 32.2 per 1000 live births in 2004, and 
33.2 per 1000 live births in 2009 (1). The same study also concluded that, based on data from 1991 to 
2009, the rate of twin births is increasing in North America This trend can be attributed to increasing 
artificial reproductive technology usage, combined with increasing maternal age, and this trend seems to 
hold across multiple developed countries (i.e. England, Germany, France and South Korea) (367).      
A comprehensive global study of twin birth rates published the following ‘natural’ twin birth 
rates: less than 8 twin births per 1000 births (low) in East Asia and Oceania; 9-16 twin births per 1000 
births (intermediate) in Europe, India and the United States, and greater than 17 twin births per 1000 
births (high) across Central Africa(373) . Past studies have found that the rate of identical (monozygotic) 
twin births is globally constant at approximately 4 per 1000 births (367) and that variations in twin birth 
rates are largely attributable to the differential birth rates of  fraternal (dizygotic) twins across 
populations(366,370).    
 
2.5.3 Types of Twins  
Differences in cell division within the first two weeks of development (see section 2.2.2) are 
crucial in determining whether a singleton or multiple pregnancy will occur. Figure 2.2 below outlines 
how twin types occur. If, at conception, two oocytes are fertilized, the resultant embryos will develop into 
dizygotic (DZ) or fraternal twins (374).  Each twin will independently undergo the aforementioned cell 
division stages, developing their own amniotic sac and placenta. This is referred to as a diamniotic 
dichorionic (DA/DC) (2 placentas) pregnancy.  Dizygotic twins share approximately 50% of their genes, 
on average (equivalent to pairs of singleton siblings)(370). Dizygotic twins are always dichorionic.   
Monozygotic (MZ) twins are derived from fertilization of a single oocyte that splits, resulting in 
(genetically) identical twins. Depending on when during development the split occurs, different forms of 
monozygotic twins can arise.  If this split occurs before the 3rd day of fertilization, the resultant twins will 
be dichorionic (DC) and diamniotic (DA), meaning that they develop 2 distinct placentas and 2 distinct 
amniotic sacs. If the split occurs after the 3rd day post fertilization, when the morula has separated, the 
resultant twins will develop in 1 placenta and 2 separate amniotic sacs, called monochorionic and 





and monoamniotic (MA), meaning that they develop within the same placenta and amniotic sac (362). 
Because of their increased proximity, MA/MC twins are at greatest risk of obstetric complications.    
 




2.5.4 Determinants of Twin Births  
Many factors have been hypothesized to be determinants of multiple births. These include: 
maternal BMI/obesity, hereditary factors, ethnicity, increasing maternal age, artificial reproductive 
technology use, smoking, seasonal variations and folic acid supplementation. (301,305–312).   
 
2.5.5 Twin Births and Fetal Growth  
Many authors and clinicians have suggested that twins may grow differently than singletons 
(224,353,386–389).  But, being a small twin does not necessarily mean the baby is unhealthy compared to 
singletons. Therefore, it follows that twins should not necessarily be assessed by singleton standards. 
However, when comparing the total “fetal mass” of a singleton and twin pregnancy, a total twin 
pregnancy will have a higher overall mass than a singleton pregnancy, leading many to consider a 
multiple gestation to be growth promoted in comparison (390,391).The utero-placental system is able to 
supply 50-75% more in a multiple gestation compared to a singleton one; an effect which holds true even 
in birth-weight discordant twins (390). This suggests that twin pregnancies are not inherently doomed, 





to note that the smaller size of multiples is not necessarily pathological in origin, and rather just a 
consequence of sharing a uterine environment.   
Growth trajectories are different between twins and singletons. Numerous studies have 
determined that the growth trajectories of twins and singletons are similar until 28 weeks gestation; after 
which, twin growth slows down (18,28,393,394). (This means that until 28 weeks, twins and singletons 
exhibit similar weights, after this, singletons go on to gain more weight until birth as compared to their 
twin counterparts).  
Several possible mechanistic explanations have been proposed for these distinct growth 
trajectories, such as crowding in the uterus, (393,395) or placental dysfunction causing hypoxia (396).   
Twins with ‘typical’ growth are not the same thing as growth restricted singletons; as different 
factors can contribute to the reduced growth.  A recent review suggests that the origins of reduced growth 
in twins are distinct from those of reduced growth in singletons (397), and may thus lead to different 
outcomes in the long term.  Studies on fetal reductions have found that singletons resulting from fetal 
reductions will still have a birth weight less than that of natural singletons (398). Monochorionic twin 
pairs more commonly experience fetal growth restriction and growth discordancy as compared to 
dichorionic pairs (49).  A 1998 study exploring the role of chorionicity found that, on average, MC twins 
weighed 66.1g (p<0.05) less than DC twins that are age-matched (390,399).  One study found that for 
same sex twins, male twins will demonstrate a greater median birth weight than female twins across all 
gestational ages(18), attributable to the presence of androgens (400).  In sex-discordant twins, the effect 
of sharing the uterine environment with an opposite sex sibling leads to longer gestation for the male 
twin, on average by 2.1 days (compared to male-male twins), and an increased birthweight for the female 
twin, on average by 102g  (compared to female-female twins) (400). 
 
2.5.6 Twins – Gaps in Knowledge 
Twins require special consideration due to increased obstetric complications that may arise from 
a multiple pregnancy, such as lower birth weight, higher rates of preterm births, fetal and infant mortality 
and long term developmental disabilities(401).   Furthermore, twin specific complications can also arise 
depending on the type of twin (i.e. MA/MZ/DZ) (362), and can range from fetal weight discordance to 
Twin to Twin Transfusion Syndrome, or even fetal loss (fetal reduction).  There is a differential obstetric 
risk between MC and DC twins, where there are increased complications in MC twins, due to placental 
sharing, and connected vascular systems (374). For instance, MC DA twins are at a 10-15% increased risk 





Owing to these aforementioned complications, twins are generally excluded from fetal studies. 
Maternal complications are also more prevalent in twin and multiple births.  For instance, maternal heart 
rate, stroke volume and cardiac output are increased in twin births, as compared to singletons.  Blood 
plasma volume in a twin pregnancy can be increased by 10 to 20% more as compared to in a singleton 
pregnancy (362). Other maternal complications specific to twin and multiple births include increased 
nausea and vomiting, increased obstetric and intrahepatic cholestasis, urinary tract changes leading to 
increased risk of urinary tract infections, higher rates of gestational hypertension and pre-eclampsia. 
Additionally, in twin pregnancies, pre-eclampsia can be more severe, and can have an earlier onset (403). 
Twin growth is poorly studied as compared to singleton growth. This is due to the increase in 
statistical complexity necessary to account for the non-independence of twin pairs.   
It is still unknown whether the factors leading to smaller size in twins are the same factors that 
lead to smaller sized (IUGR) singletons. However, the pathological conditions that would cause a 
singleton to be growth restricted are not more common in twin pregnancies; therefore smaller sizes at 
growth are not necessarily caused by the same factors(397).   
 
2.5.7 Twins – Conclusions  
Twins are an understudied population. They grow in different conditions compared to singletons, 
and therefore need to be studied separately to twins. It is important to compare and contrast growth 
patterns of twins and singletons to determine the best method of clinical management, especially to 






3 Chapter 3 – Methods 
 
3.1 Introduction  
This chapter describes the methodologies used to carry out the objectives outlined in section 1.2. 
 
3.2 Study Design  
This was a retrospective longitudinal study, using observational prospectively entered data from 
the St. Josephs Health Care/London Health Sciences Centre Perinatal Database. 
 
3.3 Data Source  
Data for this study were extracted from a citywide database of birth records from the Women’s 
Care Program based in the London Health Sciences Centre (LHSC) and Victoria Hospital in London, 
Ontario, which are used for clinical quality audits as well as research activity (404). Entries in this 
perinatal clinical database are prospectively extracted from obstetrical and medical records (405), and 
entered since 1995, and contain demographic, pregnancy, delivery and birth data from mothers and their 
newborns. An estimated 61,000 deliveries are currently in the database.  
 
3.4 Population of Interest  
Database intake and relevant study population was based out of two major birth centers serving 
London Ontario and the surrounding area.  High risk transfers from the southwest Ontario region were 
also included. Approximately 4700 live births occurred in the Middlesex-London Health Unit each year 
(406), and there were approximately 56000 live births in the region from 2006 to 2017.  This project used 
data from both mothers and their newborn singletons and twins.  
 
3.4.1 Inclusion and Exclusion Criteria  
 
Targets for inclusion in this study were all eligible singleton and twin newborns born at London 
Health Sciences Centre and Victoria Hospital in the database from June 1st, 2006 to August 31st, 2018, 
born to mothers aged 18-45 with complete pre-pregnancy BMI data. Inclusion and exclusion criteria were 





These years were chosen due to consistency of definitions of variables from 2006 to 2018, as well 
as addition of new variables collected in the database. For instance, gestational age was only recorded in 
the database as completed weeks starting Nov 1, 1995 and smoking was only included if the mother 
smoked over 1 pack of cigarettes per day, which was changed to any smoking starting Dec 1, 1998. Other 
variables with changing definitions include: drug use, multiple birth status, diabetes, and gestational 
hypertension.   Mothers’ age range of 18-45 was chosen to reflect changing definitions and changing 
clinical management of “low risk” pregnancies. 
Exclusion criteria varied for mothers and newborns.  Fetal exclusion criteria included congenital 
and/or chromosomal abnormalities, stillbirths, and significant missing exposure or outcome data. Lastly, 
values from the Robertson (1) standard for birthweight for gestational age were applied to further exclude 
individuals ineligible for further analyses. Figure 4.1 outlines how the final sample size for this study was 
achieved.  
 
3.5 Variables of interest  
The following section outlines the variables available in the perinatal database that were used to 
address the objectives of this thesis. Following a review of the literature, these variables available in the 
perinatal database were chosen to be included as covariates in the analyses. 
 





























Two original variables are required to 
derive the BMI variable; maternal 
height and maternal weight.  Maternal 
BMI was provided in the dataset as a 
calculated variable based on maternal 
pre-pregnancy height and weight data.  
To calculate BMI, the following 
formula was used: 













(16.0 - 18.49 
kg/m2) 
 
Normal BMI *ref 








used commonly by Health Canada 
(407) as well as the World Health 
Organization (408). 
For the purposes of this study, BMI 
was treated as a categorical value 
following commonly used clinical 
values. The lower limit of 16.0 kg/m2 
was set based on limits of human 
chronic energy deficiency, as 
described by Henry (2001) (409).  
*Note that extremely implausible 
values (i.e. negative values or 268.46) 
are likely due to measurement errors 
(i.e. reporting a weight in lbs 
incorrectly as kgs) 
 
Obese Class I  
(30.0-34.99 kg/m2) 
 
Obese Class II  
(35.0-39.99 kg/m2) 
 






Maternal age values are calculated in 
the dataset using the following 
formula:𝑚𝑎𝑡𝑒𝑟𝑛𝑎𝑙 𝑎𝑔𝑒 =
 𝑖𝑛𝑓𝑎𝑛𝑡 𝑑𝑎𝑡𝑒 𝑜𝑓 𝑏𝑖𝑟𝑡ℎ −
𝑚𝑎𝑡𝑒𝑟𝑛𝑎𝑙 𝑑𝑎𝑡𝑒 𝑜𝑓 𝑏𝑖𝑟𝑡ℎ.  
Age responses are provided in whole 
years in the dataset. Study inclusion 
criteria pre-specified a range of 18-45. 














 parity Three variables in the dataset were 
assessed to determine maternal parity; 
number of previous term deliveries, 
number of previous preterm deliveries, 
and number of livebirths at time of 
data collection. Mothers are coded as 
multiparous if any of the above 
variables are ≥1, and nulliparous if all 
of the above variables are 0. 








Smoking2 Smoking is specified in the dataset as 
“any smoking during pregnancy” and 
is a binary variable for data entries 
after December 1st 1998. This variable 
is only collected from June 2006 
onwards in the provincial minimal 
database.  Null entries in the database 









No smoking *ref 




Alcohol1 Alcohol use data is collected for 
women who have more than 4 drinks 
per week during the pregnancy. In 
cases where a physician is concerned 
about alcohol consumption during the 















Response options ‘yes’ and ‘partial’ 
are combined to represent any drinking 




drugs Drug use at any time during the 
pregnancy is collected as a binary 
variable in the dataset. The dataset 
defines drug use as “street drugs or 
drugs noted as having high risk for 
adverse events”.  
Original coding of the variable is 
maintained and null entries in the 




No drug use 
Any drug use  
Binary: 
 
No drug use *ref 




Cocaine1 Cocaine use is coded if used at any 
time during the pregnancy (if/when 
disclosed).  This variable is only 
collected from June 2006 onwards in 
the provincial minimal database.  
Original coding of the variable is 
maintained. Null entries in the 
















Marijuana  Any marijuana use is coded if used at 
any time during the pregnancy 
(if/when disclosed).  This variable is 
only collected from June 2006 
onwards in the provincial minimal 
database.  Original coding of the 
variable is maintained. Null entries in 
the database are treated as missing 
values in analyses. 















prescdrugs Prescription drug use is coded if used 
at any time during the pregnancy.  This 
variable is only collected from June 
2006 onwards in the provincial 
minimal database.  Original coding of 
the variable is maintained. Null entries 
in the database are treated as missing 


















Diabfeb5 This variable is coded as a 
combination of two separate diabetes 
variables: insulin dependent diabetes, 
non-insulin dependent diabetes, and 
the category “overt diabetes” from the 
variable carbohydrate disorders.  All 
diabetes variables used for analysis 
code for diabetes that is pre-existing 
and persists into the current pregnancy, 





















These variables are only present in the 
dataset from June 2006 onwards. 
Null entries in the database are treated 























The carbohydrate disorders variable 
collects information on maternal 
carbohydrate related health concerns 
during the current pregnancy.  
Carbohydrate intolerance was 
diagnosed when there was an abnormal 
reading during a 75-gram oral glucose 
tolerance test (GTT).  
 
*Note that in the original dataset, the 
carbohydrate disorders variable 
included response options for levels of 
maternal carbohydrate disorders, as 
well as overt diabetes. The diabetes 
response option was dropped from this 
variable and incorporated into the 
aggregate diabetes variable   
 
Null entries in the database are treated 
as missing values in analyses. 
*Response options are derived from 
Creasy-Resnick, Maternal Fetal 
















hypdis The hypertensive disorders variable 
was created as an aggregate of 
gestational hypertension, chronic 
hypertension and eclampsia/pre-
eclampsia by combining response 
options from the variables 
currentchronhtx, and gesthtx and 
eclampsia. (Note that in the original 
dataset, one variable coded for both 
gestational hypertension, and levels of 





















original variable was used here). 
Unknown and NULL values were 
coded as a “no”. 
 
*Response options are derived from 
Creasy-Resnick, Maternal Fetal 





















Codes for chronic hypertension.  Null 
entries in the database are treated as 

















The provided variable codes for 
gestational hypertension and pre-
eclampsia /eclampsia in one variable. 
The variable responses were separated 
to assess these options separately in 
analyses.  
Coding manual specifies “For any 
case with pre-eclampsia superimposed 
on chronic hypertension, enter code 1 
for chronic hypertension, and enter the 
appropriate code (2,3 or 4) in pre-
eclampsia/eclampsia”. 
Null entries in the database are treated 






















Placprev  Codes placental placement relative to 
the cervix (defined as ‘Implantation of 
the placenta low in the uterus either 
overlying or reaching the vicinity of 
the cervical os’ in the coding manual) 
 Response options ‘marginal’, ‘partial’, 
and ‘complete’ are combined into an 
















Null entries in the database are treated 


















Infant birth weight for gestational age 
is derived from two variables found in 
the perinatal database; birth weight, 
and gestational age at birth 
Birthweights are recorded into the 
database in grams in a birth outcomes 
form.  No upper limit was set for 
birthweight. A lower limit was set 
based on the lowest published value 
available in the chosen standards.  
Gestational age is recorded in the 
dataset as completed weeks and 
completed days. Days 1-3 will be 
rounded down to the nearest week, and 
days 4-7 will be rounded up to the 
nearest completed week. 
 
Gestational age is measured in the 
perinatal database using the best 
obstetric estimate, defined as a 
combination of a first trimester 
ultrasound scan and mothers last 
menstrual period. (404).  
 
For singletons and twins, size for 
gestational age percentiles will be 
derived from Robertson (2002) which 
includes separate sex-specific 
published values for both singletons 
and twins.  
*Please see Appendix Section E  for a 
discussion of infant size for gestational 
age, and appendix  section F for a 
chart outlining current size for 
gestational age standards and 
references – these 10th and 90th 
percentile cutoffs were used to create 









18 weeks and 
3 days to 43 

































twin The variable “DELORDER” allows 
for distinguishing between singletons 
and twins, and is coded as birth 
order/#born (i.e. a singleton would be 
entered as 1/1, and a set of twins 
would be entered as 1/2 and 2/2). 












that only twins and singletons will be 
studied.  
Fetal Sex  
 
SEX 
Fetsex1 Sex at birth is recorded when 
available. Ambiguous, unknown and 
null entries in the database are treated 


















Preterm  Preterm or premature delivery is 
defined for this study as births prior to 
37 weeks gestational age – following 
World Health Organization definitions 
(29). 
Variable Gestage1 (derived from 
GESTWK and GESTDAY) was used 




18-43 weeks  
Binary: 
 
Term ≥37 weeks 
*ref 
Preterm <37 weeks  
 
3.6 Data Cleaning Methods  
Variables of interest were assessed for outliers, or implausible values, based on known biological 
ranges.   Maternal BMI values were trimmed at values less than 16 and greater than 60, following clinical 
categorization of BMI. A lower limit for birthweight was set (110g) based on the lowest published value 
available in the chosen standards.  Newborn gestational age was recorded as ‘x weeks and y days’, which 
was converted to a numeric value for analysis. The raw data provided had many “NULL” response 
options, which could potentially represent ‘no response recorded’, ‘other’, or ‘unknown’.  Any “NULL” 
entries in the database were treated as missing values in analyses.  
 
3.7 Data Analysis  
All analyses were carried out using SAS 9.4 (SAS Institute Inc., Cary, NC) software.  Analyses 
were stratified by multiple gestations. Wald based hypothesis tests were two sided with a 5% type I error 
rate. Estimated crude and adjusted odds ratios, 95% Wald-based confidence intervals, and associated p-
values were reported for all regression models.    
 
3.7.1 Descriptive Statistics  
Descriptive analyses were completed to determine pre-pregnancy, during pregnancy, birth and 
delivery related variables, and infant characteristics for mothers of singletons and mothers of twins.  





maternal BMI category.  Means and standard deviations were reported for continuous variables.  Counts 
and percentages (frequencies and proportions) were reported for levels of categorical variables.  To assess 
differences between demographics of singletons and twins, the two sample t-test was used for continuous 
variables, and a two proportion z-test for categorical variables. To assess demographic differences 
between maternal BMI categories, one-way analysis of variance was used for continuous variables, and 
the chi squared test was used for categorical variables. Fisher’s exact test was used when the chi-squared 
test was deemed inappropriate by the software.  
 
3.7.2 Creation of the Outcome Variable – Size for Gestational Age  
We required externally published values to create our outcome variable. Using the Robertson 
(2002) (1) Canadian birthweight for gestational age standard, we categorized singletons and twins into 
SGA, AGA, and LGA categories for further analyses. 
The Robertson standard we used in our analyses consisted of approximately 556,000 singletons, 
and approximately 12,000 twin Albertan livebirths from 1985 to 1998. Similar exclusion criteria were 
applied in both studies, increasing our confidence in using these external values.  Authors created a sex-
specific birthweight for gestational age standard using the best clinical estimate of gestational age from 21 
to 44 weeks based on early 2nd trimester ultrasounds. Curves were not smoothed with the rationale that 
both birthweight and gestational age data were highly accurate.  Our choice of standard is further 
explored in the discussion and appendix sections.  
 
3.7.3 Regression Analysis 
Two different regression techniques were used to determine whether the association between 
maternal BMI and infant size for gestational age exists in the population of interest.  A logistic regression 
model was used to analyze singleton birth data, and the Generalized Estimating Equations extension of 
logistic regression was used to analyze data from twin births, to account for the paired nature of twin data. 
Within the singleton and twin groups, two distinct logistic or GEE regression models were carried 
out, comparing SGA infants to AGA infants, and comparing LGA infants to AGA infants. The reference 
categories for all regressions were the infants born to mothers with ‘Normal’ BMI.  
These comparisons were made separately in both the singleton and twin groups. Both crude and 
adjusted analyses controlling for various maternal factors known to be associated with fetal growth and 





table 3.1) were carried out.  Variables such as inter-pregnancy interval, and plasma glucose levels (that 
were discussed in the literature review) were not included in analyses, as they were not present in the 
dataset. Section D in the appendix compares the ideal variables for this study to the actual variables 
available for analysis. The regression modelled the effect of maternal pre-pregnancy BMI category on 
infant size for gestational age, controlling for variables found in the literature review found to be potential 
confounders related to the current pregnancy only (parity, current diabetes, smoking, carbohydrate 
disorders, hypertensive disorders and preterm birth). Confounding variables were assessed for model fit 
following the guidelines in Vittinghof 2012 (410,411).   
 
 
3.7.3.1 Generalized Estimating Equations Extension of Logistic Regression 
Outcomes from twins tend to be correlated. To account for this correlation, the Generalized 
Estimating Equations (GEE) extension of Logistic Regression was used.  The GEE method allows for a 
model to be fit to correlated outcomes data using a robust variance estimator to account for dependencies 
between twins (412,413). 
 
3.7.4 Interaction Analysis  
To assess whether multiple births modify the association between maternal pre-pregnancy BMI 
and infant size for gestational age, two separate models were run, assessing how multiple births modifies 
the odds of SGA, and the odds of LGA in the sample. Since singletons and twins were combined for this 
analysis, the GEE logistic regression extension will be used to account for correlated twin outcomes.  The 
interaction term “BMI*twin” was included to assess whether an interaction was present.  Underweight 
mothers were not included in this analysis as we did not have any underweight mothers that gave birth to 









4 Chapter 4 – Results  
 
 
4.1 Study Sample 
We requested births recorded in the LHSC/SJHC Perinatal Database from June 1st 2006 to August 
31st 2018.  Births were excluded from provided data for failing to meet the following inclusion criteria: 
maternal age <18y or >45y at birth, higher order births (i.e. triplets and higher multiples), stillbirths, 
congenital or chromosomal abnormalities, and significant missing outcome or exposure data, for either 
mother or infant. These criteria were applied externally by the Decision Support office located at Victoria 
Hospital where the data are housed.  A total of 32,144 infants (30,686 singleton infants and 729 pairs of 
twins) with full maternal pre-pregnancy BMI and infant birthweight for gestational age data were 
provided for inclusion in the study.  An additional 34 pairs of twins (68 infants) were excluded due to a 
matched twin having missing data, leaving 695 pairs of twins or 1390 infants for further analyses, and a 
new study sample size of 32076 infants. Lastly after applying the Robertson standard to the study 
population, and removing individuals with omitted maternal BMI values, 30396 singletons and 1346 twin 
infants, for a total of 31742 infants, were available for analysis. The Robertson standard only reported 
percentiles for the 21st to 44th weeks of gestational age, whereas births in the study population ranged 
from the 19th to 43rd weeks of gestational age.  A flow chart is provided (figure 4.7 below) outlining how 
the final sample size for this study was achieved.  
 
4.2 Description of Mothers in the Study Population  
Maternal variables are reported in table 4.1 below. The distribution of pre-pregnancy BMI classes 
was similar between mothers of singletons and twins. Maternal pre-pregnancy ‘Normal’ and 
‘Overweight’ BMI were similar between mothers of singletons and twins (50% had ‘Normal’ BMI, and 
23% had ‘Overweight’ BMI).  Twenty percent of mothers of singletons were ‘obese’, whereas 
approximately 24% of mothers of twins were ‘obese’ pre-pregnancy. Mothers in the study sample were 
on average aged 30 (singletons) and 31 (twins). Greater than 55% of mothers were multiparous.  
Fourteen percent of mothers reported smoking, and about 10% reported any drug use during the 
current pregnancy.  Less than 2% of all mothers in the study population had diabetes in the current 
pregnancy. Maternal carbohydrate disorders were more prevalent (almost doubled) in twin pregnancies 





hypertension, gestational hypertension, eclampsia, and pre-eclampsia) were also more prevalent in twin 
pregnancies (17.7%) as compared to singleton pregnancies (7.2%).  It is important to note that these data 
are based on patient self-reports and may be subject to inaccurate recall or bias.  
 
4.3 Birth and Delivery, and Infant Variables  
Birth and delivery and infant variables are presented in table 4.2 below. Singletons had higher 
birthweights than twins in this study population. Males had higher birthweights than females in both 
singletons and twins. Consistent with the literature, twins were, on average, born 4 weeks earlier than 
singletons, (414). About 50% of twins were born preterm.  
 
4.4 Outcome Variable: Birthweight for Gestational Age 
Infant birthweight for gestational age was assigned using Robertson (2002) published values and 
assessed separately in singleton and twin populations. Table 4.3 below reports size for gestational age 
distributions by fetal sex in singletons and twins. When size for gestational age was assigned using 
Robertson (2002) values, 30396 singletons met conditions (i.e. fell within the reported gestational ages 
(21-44w) available in the Robertson published standard, and were born to mothers with BMI values 
within the specified range) to be classified; of these, 10.0% (3052) of singletons were categorized as 
SGA, 79.6% (24193) of singletons were AGA, and 10.4% (3151) of singletons were LGA. In twins, 1346 
infants met the criteria to be classified; of these, 11.4% (154) were categorized as SGA, 79.1% (1064) 
were AGA, and 9.5% (128) were LGA. By definition, approximately 10% of infants should be SGA, 80% 
AGA and 10% LGA. The Robertson singleton and twin standards very closely approximate the 
theoretical distribution of size for gestational age categories. 
Table 4.4 below reports size for gestational age distributions by maternal obesity category in 
singletons and twins, stratified by sex. When stratified by sex, the size for gestational age measure retains, 
on average, the 10-80-10 distribution described earlier, which was as expected, due to the Robertson 







4.5 Associations Between Maternal BMI and Infant Size for Gestational Age  
 
4.5.1 Overall Findings  
The unadjusted relationship between maternal pre-pregnancy BMI and the risks of SGA and 
LGA, as estimated by univariable regression, are presented in table 4.5, and these relationships adjusted 
for covariates, as estimated by multivariable regression, are presented in table 4.6, and in appendix G. 
Odds of infants being born small or large for gestational age vary by both level of maternal pre-pregnancy 
obesity, and by multiple pregnancy. Adjustment for chosen covariates (parity, current diabetes, smoking, 
hypertensive disorders, carbohydrate disorders, and preterm birth) did not alter the overall pattern of odds 
of being small or large for gestational age.  
There may be evidence of a dose response relationship between increasing maternal pre-
pregnancy BMI and increasing odds of LGA. This relationship does persist both before and after 
adjustment for relevant covariates, for both singleton and twin populations. As this was not a main focus 
of this thesis, we did not explore this further. 
 
4.5.2 Small for Gestational Age 
Overall, increased maternal pre-pregnancy BMI is associated with decreased odds of giving birth 
to an SGA infant, with this association achieving statistical significance for singleton pregnancies only.  
 
4.5.3 Large for Gestational Age 
Overall, increased maternal pre-pregnancy BMI is associated with increased odds of giving birth 
to a large for gestational age infant, and this association achieved statistical significance for both singleton 
and twin pregnancies.  The twin findings for both small and large for gestational age appear to be in the 









4.5.4 Predictor Variables  
The full multivariable regression model results are presented in appendix G. The final 
multivariable model comprised of variables explored in the literature review for which there were 
sufficient sample sizes (i.e. no “zero cells”) across each category of maternal pre-pregnancy BMI for both 
singletons and twins.  Additionally, only variables related to the current pregnancy were considered in 
these analyses. Overall, the effects of predictor variables on infant odds of SGA or LGA appeared to vary 
between singleton and twin pregnancies. The variables smoking, hypertensive disorders and preterm birth 
overall contributed to infant SGA and the variables parity, diabetes and carbohydrate disorders overall 
contributed to infant LGA.  Given that the main purpose of inclusion of these variables was to control for 
potential confounding, the individual variables’ relationships to SGA and LGA are not discussed further 
below, but are presented in Appendix G. 
 
4.5.5 Adjusted models – Singletons 
Table 4.6 below reports odds of being small or large for gestational age, for singletons and twins, 
adjusted for variables discussed in the literature review and methods chapters.  Adjustment for chosen 
variables did not change the overall relationship between maternal pre-pregnancy BMI and infant SGA or 
LGA. In singletons, increased maternal pre-pregnancy BMI is associated with decreased odds of being 
born SGA both before and after adjustment for covariates. Underweight mothers had the highest odds, 
and Obese Class II mothers had the lowest odds of giving birth to SGA singletons.  Increased maternal 
pre-pregnancy BMI is associated with increased odds of being born LGA both before and after 
adjustment for covariates.  Obese Class III mothers had the highest odds and Underweight mothers had 
the lowest odds of giving birth to an LGA singleton.  
 
4.5.6 Adjusted Models – Twins  
In twins, there was generally no statistically significant association between increased maternal 
pre-pregnancy BMI and decreased odds of being born SGA, before or after adjustment for relevant 
confounders.  Obese class III mothers had the lowest odds of giving birth to an SGA twin. In twins, as 
maternal pre-pregnancy BMI increased, odds of being born LGA also increased, both before and after 





Obese Class III mothers had the highest odds of giving birth to an LGA twin. Significance was not 
reached for many of the twin comparisons, potentially due to the small sample size available for analysis. 
 
4.6 Influence of Multiple Births on the Association of Pre-pregnancy BMI and 
Infant Size for Gestational Age 
Further analyses were carried out to determine whether a statistical interaction was present in our 
population. Overall, we did not find evidence to suggest that multiple births modified the association 
between pre-pregnancy BMI and infant size for gestational age. Adjustment for chosen variables (parity, 
current diabetes, smoking, hypertensive disorders, carbohydrate disorders, and preterm birth) did not 
change this relationship.  
Multiple births did not modify the association between pre-pregnancy BMI and odds of infant 
SGA in this population (crude: p=0.29; adjusted: p=0.41). Multiple births also did not modify the 
















Pre-Pregnancy Related Variables 
Pre-Pregnancy BMI (kg/m2) n (%) 
Underweight: (16.0 -18.49) 
Normal: (18.5-24.99) 
Overweight: (25.0 -29.99) 
Obese Class I: (30.0 -34.99) 
Obese Class II: (35.0-39.99) 
Obese Class III: (40.0-60.0) 
 



































Pregnancy Related Variables 













Any Alcohol During Pregnancy  























































718 (51.7 %) 
0 (0.0%) 
<0.0001 














Missing  6 (0.02%) 0 (0.0%) 


























*Two tailed Students t-test, Fishers exact test (2-group comparisons) or Pearson chi square (categorical 
comparisons) p-values are reported  
**Maternal BMI values >16.0 and <60.0 kg/m2 were omitted from regression analyses due to low sample size 
Note: Column percentages are reported 

















Birth and Delivery Related Variables 



























































Gestational Age (weeks)  








Preterm n (%) 
<37 weeks  













*Two tailed Students’ T test (2 group means), Fishers exact Test (binary) and Pearson Chi-square test (categorical) 
derived p-values are reported  
Note: Column percentages are reported 
Note: ‘missing’ values are reported when available- variables without any ‘missing’ are assumed to have no 
‘missingness’ 






Table 4. 3 Size for Gestational Age Category for Singletons and Twins – Stratified by Fetal Sex 













































Table 4. 4 Singleton and Twin Infant Size for Gestational Age by Maternal Pre-Pregnancy BMI 




















































































































































































Table 4. 5 Unadjusted (Crude) Odds of Being Small or Large for Gestational Age by Maternal Pre-
Pregnancy BMI Category in Singletons and Twins (Female and Male Combined) Using the 

























Obese Class I 
Obese Class II  





























Obese Class I  
Obese Class II 


























Two tailed Wald test derived p-values and confidence intervals are reported  
*Note that Underweight mothers were omitted from analyses due to zero cells impeding model fit  









Table 4. 6 Adjusted Odds of Being Small or Large for Gestational Age by Maternal Pre-Pregnancy 


























Obese Class I 
Obese Class II  





























Obese Class I  
Obese Class II 

























Two tailed Wald test derived p-values and confidence intervals are reported   
Models are adjusted for mothers’ parity, current diabetes, smoking, hypertensive disorders, carbohydrate disorders 
and preterm birth. A discussion of these variables can be found in the methods chapter  
*Note that Underweight mothers were omitted from analyses due to zero cells impeding model fit  




















5 Chapter 5 – Discussion 
 
5.1 Overview 
This study examined the relationship between maternal obesity and size for gestational age in 
twins in comparison to the well-established relationship in singletons in the London Ontario population. 
Although many studies to date have explored the role of maternal pre-pregnancy obesity on fetal growth, 
few studies have focussed specifically on the outcome of size for gestational age, and fewer still have 
extended focus to twin pregnancies. Our study adds updated and relevant information regarding the 
association of maternal BMI and twin growth.  A strength of the study was the use of data from a 
common source population in London Ontario.  These results contribute to the available body of literature 
by confirming what is already known about singleton growth, as well as adding to the growing body of 
knowledge on twin growth. Results also contribute to studies on Canadian birth populations, and 
emphasize the need for further Canadian-focused, and twin-focused work.    
 
With this study, we aimed to determine the potential associations between maternal obesity and 
fetal size for gestational age in singleton and twin pregnancies. Specifically, we aimed to compare the 
odds of infant small or large for gestational age across clinical categories of maternal pre-pregnancy BMI, 
and to compare these odds in singleton and twin gestations.  
 
We had initially hypothesized that an association would be found to be present between maternal 
BMI and infant size for gestational age. It was hypothesized that decreasing maternal BMI would be 
associated with decreasing size for gestational age, and increasing maternal BMI was hypothesized to be 
associated with increasing size for gestational age, and this association was expected to be stronger in 
singletons than in twins. 
 
5.2 Interpretation of Findings 
Overall, increased maternal BMI was found to be statistically significantly associated with 
decreased odds of giving birth to an SGA infant, for singleton pregnancies only. Although there was no 
significant association found for twins, it should be noted that sample sizes were small and confidence 





increased maternal BMI and decreased odds of infant SGA and increased odds of infant LGA, in both 
singleton and twin groups.  Since none of the twin associations were statistically significant, it is not 
possible to validly compare the strength of the associations between singletons and twins. 
It was found that increased maternal BMI was associated with increased odds of giving birth to an 
LGA infant, for both singleton and twin pregnancies; this association did not attenuate appreciably after 
control for maternal diabetes or hypertensive disorders, suggesting a biologically independent effect 
remained that was not mediated through these pathways.  For twins, associations did not reach statistical 
significance, with the exception of twins born to Obese Class III mothers. It should be noted that the twin 
findings do appear to be in the same direction as those for singletons, however, sample sizes preclude 
estimating the relationships with precision and also preclude valid comparison of the strengths of the 
associations in twins and singletons. 
 
We had initially expected that singletons would have stronger associations than twins in part due 
to their growth in utero occurring in a ‘simpler’ environment. Twins have to share maternal energy 
resources in utero, and the mechanisms by which this occurs, as well as how factors such as chorionicity 
and amnionicity affect twin growth, are still being studied in humans (415). We were unable to compare 
singletons and twins due to the lack of statistical significance for most relationships estimated in twins.  It 
is possible that the lack of an association in twins was due to large variation in the strength of the 
association (i.e. the explanation was not as simple as a ‘weaker’ association) due to the complicated 
nature by which placental nutrient transfer occurs in a multiple gestation. However, the main explanation 
is likely the substantially smaller sample size for twins as compared to singletons (we only had data on 
1390 twins born over a 12-year period).  
 
Visually, odds of LGA differed substantially between singletons and twins in our population 
when stratified by maternal obesity category. We conducted further analyses to determine whether 
multiple births were modifying this association between maternal pre-pregnancy BMI and infant size for 
gestational age. While the overall tests for interaction were not statistically significant, (crude: BMI*twin: 
p= 0.29 (SGA), 0.07 (LGA); adjusted: BMI*twin: p= 0.41 (SGA), 0.26 (LGA)) odds of LGA in Obese 
Class I mothers were significant (p=0.03). This did not persist after adjustment for chosen covariates 
(p=0.1). As above, it is possible that the decreased twin sample size relative to singleton sample size 
(twins comprised about 4% of our total sample) may have contributed to this. Other explanations as to 





maternal pre-pregnancy BMI and size for gestational age are associated do not differ substantially 
between singleton and multiple gestations. To date, no studies have explored the role of multiple births in 
modifying the association between maternal pre-pregnancy BMI and infant size for gestational age.  As 
such, it is difficult to make comparisons, or place these results relative to other literature in the field.  
 
We considered the idea of maternal obesity being a ‘protective factor’ against the ‘smallness’ 
present in twins. As increasing maternal obesity contributes to fetal growth, it would lead to a right shift 
of the population birthweight curve (i.e. shift favouring increased birthweights), whereas the factor of 
multiple pregnancy would shift the population birthweight curve to the left (i.e. shift favouring decreased 
birthweights). However, because a twin-specific birthweight distribution was used to classify SGA and 
LGA in twins, the latter effect was accounted for in the study design.  Therefore, we expected our results 
to reflect the effect of maternal BMI with control for the covariates available.  Shifts in birthweight curves 
have also been described in relation to maternal smoking (416). Evidence does exist to suggest that 
gestational weight gain plays a strong role in determining size for gestational age in both singletons and 
twins. We suspect that having gestational weight gain data would have refined our results.  
Our results are consistent with current literature (351,417–419) exploring the role of maternal 
BMI in relation to fetal growth in singletons.  Few have explored this association in twins, and fewer 
studies still have compared both singletons and twins in one study. One such study, Hinkle et al. (2016) 
(420), aimed to determine the association between infant size for gestational age and mothers’ pre-
pregnancy BMI, and how this affected perinatal mortality in singletons.  Similar to our study, Hinkle et al. 
determined that risk of SGA was decreased in mothers with increased BMI, and this was replicated using 
three different measures of infant size for gestational age (a population based reference, an estimated fetal 
weight based reference, and a customized reference based on maternal characteristics and fetal sex). 
Another study,  Gaillard et al. (2013) (417), focused on both maternal pre-pregnancy obesity and 
gestational weight gain, as well as their risk factors, and reported that increased maternal obesity was 
associated with increased odds of giving birth to an LGA (singleton) infant (OR:2.97, 95%CI:2.16-4.08).   
 
Fox et al. (2013) (23) explored the effects of maternal obesity on adverse outcomes in twin 
gestations only, however, this study did not focus on growth-related outcomes.  Colletto et al. (2005) did 
study the effect of maternal BMI on twin anthropometric measures (360). Authors found no significant 
correlation between maternal pre-pregnancy BMI and newborn weight or BMI. Gestational weight gain, 





Lucovnik et al. (2014) (353) is one of the few studies that did compare singletons and twins 
within the same study, finding that maternal obesity increased risk of preterm births in both groups. 
However, no fetal growth related outcomes were explored.  A recent study that was very similar to ours 
used the BORN Ontario database to assess the role of gestational diabetes on singleton and twin 
pregnancies (421). This study used the 2001 Kramer (singleton only) reference to assess size for 
gestational age in both singletons and twins in their study population. Authors used a modified 
Poisson regression with robust error variance to determine risk ratios for their outcome of interest, and 
similarly to our methods, the GEE method was used to account for twin non-independence. They 
hypothesized that gestational diabetes would have a protective effect against adverse pregnancy 
outcomes in twins, as compared to singletons. Authors found that gestational diabetes was associated 
with increased birthweight (>90th percentile) in both groups, with twins having 2 times higher risk 
than singletons. Due to their use of a singleton standard to assess twins, it is difficult to compare to 
our study. 
Study Validity  
Due to the theoretical 10-80-10 distribution of the size for gestational age measure used in our 
study, we were able to assess the suitability of the standard used to classify our outcomes. In particular, 
we would anticipate that approximately 10% of our population would be SGA and 10% LGA if the 
standard chosen was appropriate.  This expectation was very closely approximated, across singletons and 
twins, and this distribution persisted when stratified by fetal sex. This indicates that the Robertson (2002) 
standard was a reliable external standard to use in our study.  
Selection of this standard was done a-priori and based on the following criteria:   Reporting 
birthweight in grams per gestational age in weeks, providing separate values for female and male infants, 
inclusion of live births only, and no estimated fetal weight values (i.e. no ultrasound values). Section F of 
the Appendix outlines the main standards reviewed and considered for this project. Based on our literature 
review, 5 studies (Robertson 2002, Kramer 2001, Joseph 2009, Arbuckle 1993, and Ghi 2017 
(1,19,32,422,423)) were chosen for consideration.  We decided to remove the Arbuckle study from 
consideration as the Kramer standard represents its updated version. However, the Kramer standard was 
deemed unsuitable for a different reason: it only reported singleton birthweight for gestational age 
percentiles.  Our literature review determined that there was a need for separate singleton and twin 
standards.  Ultimately, we decided to only use the Robertson (2002) standard because it incorporated the 
widest ranges of birthweights and gestational ages in their percentiles.  Robertson (2002) reported values 
for singletons and twins, female and male, for 21-44 weeks gestational age. Joseph (2009) reported values 





also had maternal ethnicity based exclusion criteria, and were based on an American birth population, 
whereas the Robertson standard was Canadian (Alberta), and established inclusion and exclusion criteria 
similar to the ones in this study. Lastly, the Ghi (2017) study only reported 16-36 weeks gestational age, 
(the majority of births in the London cohort were ≥37 weeks) and while they specified twin chorionicity 
for their standards, they were not divided by fetal sex. As discussed elsewhere in this chapter, our ability 
to replicate the ‘10-80-10 distribution’ of size for gestational age for both singletons and twins using an 
external standard solidifies the legitimacy of our decision to use this standard.    
 
Hiersch et al. (2019) (421) used the Kramer 2001 Canadian standards to assess SGA and LGA 
in singletons and twins in their study, despite the fact that the Kramer standards were developed based 
on singletons.  Their data demonstrate that this standard does not apply well to twins:  singletons in 
the study approximated the ‘10-80-10’ distribution for size for gestational age (SGA: 9.0 % (GDM 
group), 9.2% (non-GDM); LGA: 13.1% (GDM), 9.1 %( non-GDM)), whereas twins did not (SGA: 
23.4% (GDM), 26.3% (non-GDM); LGA: 3.2% (GDM), 1.3% (non-GDM)).   Authors make no 
comment on their use of a singleton standard to assess both singletons and twins.   
Singleton standards have previously been used to assess multiple pregnancies (424), however, 
this method tends to result in a greater number of healthy twins being classified as SGA or growth 
restricted, especially at later gestational ages (425).  Evidence exists to suggest that singleton 
anthropometric measurement charts may be more applicable to assess uncomplicated twin pregnancies 
(224,426) as compared to size for gestational age charts. Visual assessment of Robertson singleton 
percentile values and London population twin values suggests that a majority of twin births would be 
incorrectly classified, had we used a singleton size for gestational age measure to assess twins.  
 
 Our mean birthweights were within 5% of the mean birthweights recorded in the Robertson 
standard, which was based on a much larger population (singleton n=556,775; twin n=12125). However, 
since the differences were within 5%, it may confirm that selecting the Robertson standard was a valid 
approach to analysing this study population.  
 
Hinkle 2016 (420) used an external standard to assess size for gestational age in their population 
(Hadlock et al. (1991) In utero analysis of fetal growth: A Sonographic Weight Standard (427)). They 





used were a population based reference, an estimated fetal weight based reference, and a customized 
reference based on maternal characteristics and fetal sex). This paper analysed first born singletons only.  
Studies such as Callaghan et al. (2010) and Dietz et al. (2009) (428,429) explored how different 
methods of calculating gestational age can affect the size for gestational age measure. Callaghan (2010) 
compared clinical, obstetric, last-menstrual-period (LMP) based, and ‘gold-standard’ (clinical or obstetric 
and LMP based estimates agree) based estimates, and suggested that size for gestational age can further 
vary depending on how gestational age in the measure is calculated. Authors suggested that LMP-based 
estimates were the most different, and may need to be revisited, especially when used in size for 
gestational age calculations. This may suggest that use of external standards is validated when the method 
of obtaining the gestational age is similar between source and analysis populations.  Both our study and 
the Robertson study used a ‘best estimate’ based on a combination of ultrasound scan and last menstrual 
period to derive a gestational age.  
 
It is important to note the conceptual limitations of using maternal BMI as our measure of 
maternal obesity. BMI, while useful, fails to detect subtle nuances in natural variations in human size. 
Specifically, BMI is a measure of relative weight, not body fat distribution, and therefore is unable to 
differentiate between varying body compositions (430,431). There is a subset of ‘healthy obese’ 
individuals who are likely being misrepresented as having high risk pregnancies. More ‘direct’ measures 
of obesity, such as bioelectrical impedance testing (432) were not available for use in this analysis.  
 
5.3 Study Strengths  
Strengths of this study include the use of retrospective cohort data from a large, single-population 
database. This allowed for a large singleton sample size, and comparatively large twin sample size.  
We used an external outcome measure that was specific for singletons and twins – which allowed 
us to validly evaluate singleton and twin size for gestational age.  
We also incorporated a unique statistical method to account for twin non-independence, the 
Generalized Estimating Equations (GEE) extension of logistic regression. Countless studies on twin 
pregnancies make no mention of accounting for the matched nature (non-independence) of twin data 
(433–438).  Carlin et al. (2005) (413) recently published a review outlining various ways regression 





valid estimation of standard errors around the regression coefficients as compared to a basic logistic 
regression. 
Another strength of our study was the comparison of singleton and twins from the same 
population in one study; while some studies do compare the two groups, the majority of studies tend to 
focus exclusively on singletons or exclusively on twins. As seen above, studies that do assess twin 
outcomes do not always use the best available statistical methods.  Incorporating both groups into one 
study and using the appropriate statistical methods to analyze them allows for more valid findings.   
 
5.4 Study Limitations 
There were a few limitations we encountered during this project.  This was a prospective study 
design but used retrospective data.  Prospective data collection, while infeasible for a Masters Thesis 
project, would have allowed for greater control over variable measurement and collection, and would 
have allowed for greater diligence on prevention of missing values.  
There were many important variables we did not have available to incorporate into our analyses 
due to limitations of the database. These included gestational weight gain, socio-economic status related 
variables, multiple children from one mother (presence of siblings), and types of twins (zygosity).  
Gestational weight gain is a particularly important missing variable. While the database does have a code 
for gestational weight gain, it does have data reflecting insufficient weight gain (coded as “weight gain 
less than 10 lbs)” and excess weight gain (coded as “weight gain greater than 20 kgs”) and would not 
have contributed as meaningfully to analyses as a continuous variable would have.  The medical records 
underlying the data entered into the database captured inadequate and excess weight gain separately, as 
two different “risk factors” and inconsistent measures (lbs and kgs) exist in the primary medical record.    
Numerous studies support the role of gestational weight gain as an important determinant of infant size 
for gestational age, in both singleton and twin pregnancies, perhaps even more so than pre-pregnancy 
BMI (439). 
Other particularly important missing variables are measures of socio-economic status and/or maternal 
demographic characteristics.  Evidence does exist to suggest that factors such as maternal race, and 
educational attainment can have some effect on fetal growth (19,440).  We were unable to account for 
indicators of socioeconomic status, as many variables commonly used as proxies for SES were not 
collected in the SJHC/LHSC Perinatal database. Two potential SES proxy variables were collected in the 





based on suggestions that it may be a poor proxy for SES in modern times and is no longer the robust 
predictor of fetal health and growth that it was once considered to be. Numerous studies have explored the 
role of marital status on fetal growth related outcomes (441), finding that infants born to mothers in 
common law partnerships have similar outcomes to those born to married mothers.  The other potential 
SES proxy, mothers’ educational attainment, has very poor completion rates in the data source, and th 
missing data rate would prevent us from making valid conclusions about the entire maternal population 
studied.    
We were unable to account for potential siblings in the dataset.  As our data span 12 years and 
contains over 30,000 infants it is highly likely that siblings from other pregnancies to a shared mother 
exist in our analyses. This is an important factor to consider, as, just like twins, siblings represent a non-
independent cluster of data.   
Another factor we were unable to identify in our dataset was the specific type of twin 
(i.e.MC/DC, MA/DA, MZ/DZ (or, identical v. fraternal)). As explored in the literature review chapter, 
differences between twin types are significant enough to warrant stratifying them in our analyses. In fact, 
the Ghi (2017) standard published values stratified by chorionicity.   
The self-reported nature of variables such as pre-pregnancy weight, smoking, alcohol use and 
drug use likely resulted in under-reporting. In some instances, self-report is the only available means of 
data collection. This has been documented in numerous studies(442–446). 
In terms of conceptual limitations, it is important to note that accurate assessment of birth weight, 
size, or growth happens after birth.  While ultrasound measurements can be taken, they are only estimates 
– ultrasound values were not available for this study. This limited our ability to use common formulas in 
the field, specifically, the Hadlock formulas for estimated fetal weight (427).  
 
We discussed earlier in the literature review chapter how the size for gestational age measure can 
be useful in diagnosing at risk newborns.  Ultimately, we were unable to make any statements about 
whether SGA/LGA individuals in our dataset were healthy, or whether their size was associated with 
adverse health effects. While the size for gestational age measure is interesting, its (clinical) utility lies in 
its ability to identify infants at risk for further adverse health outcomes.  This, however, could be explored 







5.5 Future Work and Conclusions 
There are many potential avenues for future studies inspired by the work done in this thesis.   
Changing trends in parental obesity (increasing obesity over time) and increasing birthweights 
and how these factors affect odds of infant SGA or LGA is another potential avenue to explore. A year to 
year comparison of changing odds of SGA/ LGA would have been interesting to explore, and would have 
been highly relevant to the ongoing ‘obesity epidemic’. While this would have been possible in the 
singleton population, we likely did not have the sample size to accurately study this in twins. 
There were many variables of interest unavailable for analysis in the current dataset. These 
include many measures of socioeconomic status, such as ethnicity, or income level. which may be useful 
to identify mothers who may be at higher risk of adverse birth/delivery related outcomes. Other missing 
variables that are of interest to the research question include gestational weight gain. Ideally the current 
dataset would start collecting more comprehensive information on gestational weight gain (i.e. actual 
amount of weight gained), however, this variable was not collected reliably in the records from which 
data were extracted for the database throughout the duration of the study period.   
As discussed earlier, we did not have the means to identify potential siblings in the dataset. As the 
available data ranged from 2006-2018, it is very possible that one mother would have multiple birth 
events recorded in our dataset.  Statistically, these siblings are non-independent, and would need to be 
analyzed using a method that accounts for this (such as the GEE approach used for twins).  Understanding 
how fetal growth is affected by maternal body mass index in siblings would add to these results.   
 
In conclusion, evidence from this study suggests that maternal BMI influences the growth of both 
singletons and twins.  While the magnitude of the effect may differ for singletons and twins, we were 
unable to draw this conclusion. Although the study of twins increases the complexity of a study, tools 
do exist to make valid study of twins possible and our study is an example of this.  Our study fills an 
important gap in knowledge not met by current literature, and adds to the growing body of knowledge 
on singleton and twin growth as affected by maternal obesity and factors comorbid with obesity. 
Overall, these results reiterate the idea that singletons and twins are different (from a statistical or 
methodological perspective), and should be treated as such. Studies continuing to compare these 
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C: Sample Size Calculations 
Sample size (n) for logistic regression modelling the predictor variable maternal obese body mass index 
(BMI) vs ‘normal’ BMI on the prevalence (p) of infant small for gestational age (SGA) vs average for 








𝜷𝟐 ∗ 𝒇(𝟏 − 𝒇) ∗ 𝒑(𝟏 − 𝒑)
 
Sample size was estimated for the first objective with two tailed alpha value (𝑧1−𝛼
2
) set at 0.05, and 80% 
power (𝑧𝛾).  Sample size calculations are limited to a range of odds ratios (𝑒
𝛽) based on published data of 
SGA vs AGA in mothers with obese vs normal BMI (447).  Prevalence of maternal obesity ranges from 
10 to 20% in published data (448–450), while the prevalence of SGA ranges from 3 to 16% in published 
data (449–451). This comparison is anticipated to have the lowest sample size, therefore, the study will be 
sufficiently powered to examine other comparisons of maternal BMI on infant size for gestational age.  
 
Sample Size for Singletons  
For singletons, a minimum sample size of 18 to 1537 is determined based on the aforementioned 
range of conditions.   
Prior studies using this dataset reported that the dataset contains approximately 41000 singleton births 
from 2001 to 2011(452).   
Sample size for singletons modelling maternal BMI (exposure) comparing obese vs normal BMI, on the 
study outcome of infant size for gestational age comparing small vs average for gestational age: 
Z-Alpha Z- Power Odds Ratio 






Sample size  
1.96 0.84 0.25 0.106 0.164 368 
1.96 0.84 0.25 0.106 0.115 496 
1.96 0.84 0.25 0.106 0.034 1537 
1.96 0.84 0.25 0.16 0.164 260 
1.96 0.84 0.25 0.16 0.115 350 
1.96 0.84 0.25 0.16 0.034 1084 
1.96 0.84 0.25 0.2 0.164 218 
1.96 0.84 0.25 0.2 0.115 294 
1.96 0.84 0.25 0.2 0.034 911 
1.96 0.84 0.595 0.106 0.164 184 
1.96 0.84 0.595 0.106 0.115 248 
1.96 0.84 0.595 0.106 0.034 769 
1.96 0.84 0.595 0.16 0.164 130 
1.96 0.84 0.595 0.16 0.115 175 
1.96 0.84 0.595 0.16 0.034 542 
1.96 0.84 0.595 0.2 0.164 109 
1.96 0.84 0.595 0.2 0.115 147 





1.96 0.84 0.86 0.106 0.164 108 
1.96 0.84 0.86 0.106 0.115 146 
1.96 0.84 0.86 0.106 0.034 452 
1.96 0.84 0.86 0.16 0.164 76 
1.96 0.84 0.86 0.16 0.115 103 
1.96 0.84 0.86 0.16 0.034 319 
1.96 0.84 0.86 0.2 0.164 64 
1.96 0.84 0.86 0.2 0.115 86 
1.96 0.84 0.86 0.2 0.034 268 
 
 
Sample Size for Twins 
For twins in objective one, the sample size (n) for a logistic regression modelling the predictor variable (f) 
maternal ‘normal’ body mass index (BMI) vs obese BMI on the prevalence of outcome (p) infant small 
for gestational age (SGA) vs average for gestational age (AGA) was determined using the following 
formula, derived from Vittinghoff (410).  A design effect factor (1 + (m0 − 1) and intraclass correlation 
coefficient (ICC) are included in the calculation to account for clustering of twin pairs, and the correlated 








𝜷𝟐 ∗ 𝒇(𝟏 − 𝒇) ∗ (𝒑(𝟏 − 𝒑)
)(𝟏 + (𝒎𝟎 − 𝟏)(𝑰𝑪𝑪)) 
Mean cluster size is set at 2; clustering in this study is based on individual twin pairs. A range of 
estimated ICC values are tested. All other values are held consistent with calculations for singleton 
sample size.  
For twins, a minimum sample size ranging from 80 to 3075 is required.  
Sample size for twins modelling maternal BMI (exposure) comparing obese vs normal BMI, on the study 
outcome of infant size for gestational age comparing small vs average for gestational age: 












Sample Size  
1.96 0.84 0.25 0.106 0.164 2 0.25 460 
1.96 0.84 0.25 0.106 0.115 2 0.25 620 
1.96 0.84 0.25 0.106 0.034 2 0.25 1922 
1.96 0.84 0.25 0.16 0.164 2 0.25 325 
1.96 0.84 0.25 0.16 0.115 2 0.25 437 
1.96 0.84 0.25 0.16 0.034 2 0.25 1355 
1.96 0.84 0.25 0.2 0.164 2 0.25 273 
1.96 0.84 0.25 0.2 0.115 2 0.25 367 
1.96 0.84 0.25 0.2 0.034 2 0.25 1821 
1.96 0.84 0.595 0.106 0.164 2 0.25 230 
1.96 0.84 0.595 0.106 0.115 2 0.25 310 
1.96 0.84 0.595 0.106 0.034 2 0.25 961 
1.96 0.84 0.595 0.16 0.164 2 0.25 162 





1.96 0.84 0.595 0.16 0.034 2 0.25 678 
1.96 0.84 0.595 0.2 0.164 2 0.25 136 
1.96 0.84 0.595 0.2 0.115 2 0.25 184 
1.96 0.84 0.595 0.2 0.034 2 0.25 569 
1.96 0.84 0.86 0.106 0.164 2 0.25 135 
1.96 0.84 0.86 0.106 0.115 2 0.25 182 
1.96 0.84 0.86 0.106 0.034 2 0.25 565 
1.96 0.84 0.86 0.16 0.164 2 0.25 95 
1.96 0.84 0.86 0.16 0.115 2 0.25 129 
1.96 0.84 0.86 0.16 0.034 2 0.25 399 
1.96 0.84 0.86 0.2 0.164 2 0.25 80 
1.96 0.84 0.86 0.2 0.115 2 0.25 108 
1.96 0.84 0.86 0.2 0.034 2 0.25 335 
1.96 0.84 0.25 0.106 0.164 2 0.5 552 
1.96 0.84 0.25 0.106 0.115 2 0.5 744 
1.96 0.84 0.25 0.106 0.034 2 0.5 2306 
1.96 0.84 0.25 0.16 0.164 2 0.5 390 
1.96 0.84 0.25 0.16 0.115 2 0.5 525 
1.96 0.84 0.25 0.16 0.034 2 0.5 1626 
1.96 0.84 0.25 0.2 0.164 2 0.5 327 
1.96 0.84 0.25 0.2 0.115 2 0.5 441 
1.96 0.84 0.25 0.2 0.034 2 0.5 1366 
1.96 0.84 0.595 0.106 0.164 2 0.5 276 
1.96 0.84 0.595 0.106 0.115 2 0.5 372 
1.96 0.84 0.595 0.106 0.034 2 0.5 1153 
1.96 0.84 0.595 0.16 0.164 2 0.5 195 
1.96 0.84 0.595 0.16 0.115 2 0.5 262 
1.96 0.84 0.595 0.16 0.034 2 0.5 813 
1.96 0.84 0.595 0.2 0.164 2 0.5 164 
1.96 0.84 0.595 0.2 0.115 2 0.5 220 
1.96 0.84 0.595 0.2 0.034 2 0.5 683 
1.96 0.84 0.86 0.106 0.164 2 0.5 163 
1.96 0.84 0.86 0.106 0.115 2 0.5 219 
1.96 0.84 0.86 0.106 0.034 2 0.5 678 
1.96 0.84 0.86 0.16 0.164 2 0.5 115 
1.96 0.84 0.86 0.16 0.115 2 0.5 154 
1.96 0.84 0.86 0.16 0.034 2 0.5 478 
1.96 0.84 0.86 0.2 0.164 2 0.5 96 
1.96 0.84 0.86 0.2 0.115 2 0.5 130 
1.96 0.84 0.86 0.2 0.034 2 0.5 402 
1.96 0.84 0.25 0.106 0.164 2 0.75 645 
1.96 0.84 0.25 0.106 0.115 2 0.75 868 
1.96 0.84 0.25 0.106 0.034 2 0.75 2690 
1.96 0.84 0.25 0.16 0.164 2 0.75 454 
1.96 0.84 0.25 0.16 0.115 2 0.75 612 
1.96 0.84 0.25 0.16 0.034 2 0.75 1897 
1.96 0.84 0.25 0.2 0.164 2 0.75 382 
1.96 0.84 0.25 0.2 0.115 2 0.75 514 





1.96 0.84 0.595 0.106 0.164 2 0.75 322 
1.96 0.84 0.595 0.106 0.115 2 0.75 434 
1.96 0.84 0.595 0.106 0.034 2 0.75 1346 
1.96 0.84 0.595 0.16 0.164 2 0.75 227 
1.96 0.84 0.595 0.16 0.115 2 0.75 206 
1.96 0.84 0.595 0.16 0.034 2 0.75 949 
1.96 0.84 0.595 0.2 0.164 2 0.75 191 
1.96 0.84 0.595 0.2 0.115 2 0.75 257 
1.96 0.84 0.595 0.2 0.034 2 0.75 797 
1.96 0.84 0.86 0.106 0.164 2 0.75 190 
1.96 0.84 0.86 0.106 0.115 2 0.75 255 
1.96 0.84 0.86 0.106 0.034 2 0.75 791 
1.96 0.84 0.86 0.16 0.164 2 0.75 134 
1.96 0.84 0.86 0.16 0.115 2 0.75 180 
1.96 0.84 0.86 0.16 0.034 2 0.75 558 
1.96 0.84 0.86 0.2 0.164 2 0.75 112 
1.96 0.84 0.86 0.2 0.115 2 0.75 151 
1.96 0.84 0.86 0.2 0.034 2 0.75 469 
1.96 0.84 0.25 0.106 0.164 2 2.0 737 
1.96 0.84 0.25 0.106 0.115 2 2.0 992 
1.96 0.84 0.25 0.106 0.034 2 2.0 3075 
1.96 0.84 0.25 0.16 0.164 2 2.0 519 
1.96 0.84 0.25 0.16 0.115 2 2.0 700 
1.96 0.84 0.25 0.16 0.034 2 2.0 2168 
1.96 0.84 0.25 0.2 0.164 2 2.0 436 
1.96 0.84 0.25 0.2 0.115 2 2.0 588 
1.96 0.84 0.25 0.2 0.034 2 2.0 1821 
1.96 0.84 0.595 0.106 0.164 2 2.0 368 
1.96 0.84 0.595 0.106 0.115 2 2.0 496 
1.96 0.84 0.595 0.106 0.034 2 2.0 1538 
1.96 0.84 0.595 0.16 0.164 2 2.0 260 
1.96 0.84 0.595 0.16 0.115 2 2.0 350 
1.96 0.84 0.595 0.16 0.034 2 2.0 1084 
1.96 0.84 0.595 0.2 0.164 2 2.0 218 
1.96 0.84 0.595 0.2 0.115 2 2.0 294 
1.96 0.84 0.595 0.2 0.034 2 2.0 911 
1.96 0.84 0.86 0.106 0.164 2 2.0 217 
1.96 0.84 0.86 0.106 0.115 2 2.0 292 
1.96 0.84 0.86 0.106 0.034 2 2.0 905 
1.96 0.84 0.86 0.16 0.164 2 2.0 153 
1.96 0.84 0.86 0.16 0.115 2 2.0 206 
1.96 0.84 0.86 0.16 0.034 2 2.0 638 
1.96 0.84 0.86 0.2 0.164 2 2.0 128 
1.96 0.84 0.86 0.2 0.115 2 2.0 173 







D: Ideal and Available Variables for Analysis 
Figure 6.6: Ideal Variables based on the literature review, vs variables available for analysis in the 
LHSC/SJHC perinatal database  
 
> Perinatal database 
COVARIATES
Chart No. 
Infant _ of _ 
Most responsible diagnosis - to detm twins 
maternal age
maternal height in cm
maternal height in inches
maternal pre-pregnancy weight kg
maternal ore-pregnancy weight in lb
Other risk factors- "W" wt gain <10 lb by 30 weeks 
Other risk factors- "X" wt gain >20 kg
I/P OB consult, # of previous term deliveries ; #of previous preterm deiveries 






disorders of multiple gestation
diabetes -insulin dependent


































































































































































































































































































E: Considerations for Infant Size for Gestational Age  
Separate measures exist for singleton and twin births.  These measures can either be standards or 
references; a population based standard only includes low risk “optimal” births, whereas a reference aims 
to include all births (i.e. abnormal birth outcomes are included in the development of the reference) (21).  
Standards and references have different utilities; a standard is useful in diagnosing abnormally grown 
infants, whereas a reference allows one to place the growth of the infant relative to the population from 
which the reference was derived (21). Authors of this paper suggest that greater clinical utility exists in 
growth standards, as compared to growth references. 
Hutcheon and Platt (2007) recommend that birth weight for gestational age references and standards be 
developed using term births only – to account for the issue of missing birth weight data at extreme 
gestational ages, as well as the idea that infants born preterm may not necessarily be ‘normal’ pregnancies 
(33). 
 
For this study, two options were considered to address/determine the fetal size for gestational age ‘cut 
points’.  One option is to use values from an already existing standard. Table 6.8a below outlines recent 
standards for singleton and twin populations. These values are commonly used by other studies, and using 
these values will allow for these results to be directly comparable to those in this study and others using 
this methodology. The second option was to determine ‘internal’ 10th and 90th percentile values for each 
gestational age for male and female infants, for singletons and for twins. These values would only apply 
internally and may allow for a good comparison of London population percentiles to the population level 
percentiles. However, this would be based on a smaller sample size (approx. 40 thousand) compared to 
the approximately 1 million infants used in the Kramer (32) standards.  
Singleton standards have previously been used to assess multiple pregnancies (424), however, this 
method tends to result in a greater amount of healthy twins being classified as small for gestational age or 
growth restricted, especially at later gestational ages (425).  Evidence exists to suggest that singleton 
anthropometric measurement charts may be more applicable to assess uncomplicated twin pregnancies 
(224,426) as compared to size for gestational age charts. 
 
Customized vs. General standards/references 
Standards and references can be customized to account for factors such as, but not limited to: maternal 





“best” way to develop a standard, however, there will be certain standards/references that will be better 
suited to the analyses being carried out in this thesis. The exclusion/inclusion criteria outlined below aim 
to address this. Studies such as the INTERGROWTH-21 project (453) have attempted to create an all 
encompassing, global reference, using ultrasound based measurements across 8 populations. Authors of 
this study suggest that a general standard is useful because less than 3.5% of growth variability can be 
explained by population-level differences (454).  However drawbacks exist when using just one 
standard/reference for such a heterogeneous population (290), such as misclassification of infants at risk.  
Gardosi (2005) suggests that using an inappropriate standard has the potential to cause more harm to 
incorrectly identified babies (167). Hutcheon et al. used an interesting approach, using the concept of 
growth potential to create a simulated cohort of ‘healthy’ and ‘growth restricted’ newborns (where growth 
restriction was reproduced in the simulation by decreasing birthweights of 5% of the cohort from their 
‘optimal’ value). They suggest that customized percentile charts offer minimal value over general ones, 
when identifying infants with IUGR(455) .  Global references are not recommended by some authors 
(456). 
Customization has the potential to allow for better diagnosis of infants that are small or large for 
gestational age due to a pathological condition (54,290), and many customized standards and references 
have been published recently.  A 2001 Swedish birth study found that customized standards are better 
able to detect individuals at increased risk of adverse health outcomes such as stillbirth and neonatal 
death, as compared to a population based standard (60). Other studies have also replicated these findings 
(59,457,458). Growth curves customized for maternal factors (i.e. height, weight, parity, ethnicity and 
smoking status) have also proved beneficial in identifying large for gestational age births (459).   
Additionally, customization of growth standards can lead to a reduction in the rate of false positive 
diagnoses of growth restriction (458).  One 2008 study, however, found that standards customized to 
maternal characteristics are no different from non-customized standards when using them to predict 
morbidity and mortality in the perinatal period (460).  The NICHD Fetal Growth study found that 
significant differences in fetal growth exist across ethnicities in the United States, and thus support the 
need for customized standards and references (102).  These findings have been replicated in global studies 
as well. Authors of the 2017 World Health Organization fetal growth charts argue that current standards 
and references are “of uncertain general applicability” due to source populations being mainly from high-
income countries (461), and thus created a new reference including a variety of populations from 10 
countries. The charts demonstrate high variability in birth weight across the populations studied and 
found evidence to suggest that parity, maternal age, height and weight and fetal sex can partially explain 
these differences in birthweight. The authors do suggest that adjustment of the charts to the local 





studies selected women with low risk pregnancies, without any health or environmental concerns or 
socioeconomic constraints. A 2006 French study sought to compare customized and general birth weight 
standards in their ability to determine infants at risk of being growth restricted. Using customised 
standards allowed for the identification of 2.7% of average for gestational age births that were reclassified 
to be small for gestational age.  These reclassified small for gestational age infants were born to mothers 
with higher weight, height and parity, as compared to infants that were not reclassified (58). Numerous 
other studies support the use of customized charts to assess fetal growth (59,60,458,462). Customized 
charts have been shown to be effective in identifying at risk twins as well  (463). 
 
Criteria for using an external standard 
For this study, certain criteria were set to choose the best possible standard/reference.  These include: 
Reporting birthweight in grams per gestational age in weeks (i.e. no graphics), providing separate values 
for female and male infants, based on live births, no estimated fetal weights (i.e. no ultrasound values), 
needs to report twin values if possible, and needs the largest possible range of gestational ages (in weeks).  
Section 6.5 of the Appendix outlines the main studies considered for this project. Initially, studies 1-5 
(Robertson 2002, Kramer 2001, Joseph 2009, Arbuckle 1993, and Ghi 2017) were considered for further 
analysis.  As the project progressed, we decided to remove the Arbuckle study, due to the Kramer study 
being an updated version of it. Later, we also removed the Kramer study because it only reported 
singleton birthweight for gestational age percentiles. We had considered using the Kramer standard to 
assess both singletons and twins, however, our literature review determined that there was a need for 
separate singleton and twin standards, due to singleton standards being unable to accurately assess size for 
gestational age in twins (this is discussed in the literature review chapter).  Ultimately, we decided to 
only use the Robertson 2002 standard because it incorporated the widest ranges of birthweights and 
gestational ages in their percentiles.  Robertson (2002) reported values for singletons and twins, female 
and male, for 21-44 weeks gestational age. Joseph (2009) reported values for 36-42 weeks gestational age 
only, which would have decreased our sample size. The Joseph paper also had maternal ethnicity based 
exclusion criteria, and were based on an American birth population, whereas the Robertson standard was 
Canadian (based in Alberta), and established inclusion and exclusion criteria highly similar to the ones in 
this study. Lastly, the Ghi (2017) study only reported 16-36 weeks gestational age, (the majority of births 
in the London cohort were ≥37 weeks) and while they specified twin chorionicity for their standards, they 
were not divided by fetal sex. As discussed in the results and discussion chapters, the fact that we were 
able to obtain the ‘10-80-10 distribution’ of size for gestational age for both singletons and twins using an 
external standard solidifies the validity of our decision to use this standard.  




F: Current Infant Size for Gestational Age References and Standards  
 REFER
ENCE 




















Albertan live births from 1985 to 
1998  
-556,775 live born singletons 
-12,125 live born twins 
- data are from (from computerized 
livebirth and still birth registries 
from Alberta Registries- vital 
statistics- province of Alberta) 
 
Exclusions:  
-triplets and higher order gestations 
-individuals with missing 
birthweight or gestational age 
- gest age outside of range (22-44) 
 
GESTATIONAL AGE RANGE:  
21-44 weeks  
 
TWINS INCLUDED?: 
Singletons and twins  
 
-curves were not smoothed  
-Gestational age measured in 
completed weeks  
-Best estimate based on early 
second trimester ultrasound 
when possible, or first day of 
last menstrual period (LMP) 
otherwise. 
- Birth weight measured using a 
calibrated beam scale with non 
detachable weights – baby is 
nude for weighing  
-Weight is measured within 1 
hr of birth 
-Authors report 1st, 3rd, 
5th, 10th, 25th, 50th, 75th, 
90th, 95th, 97th and 99th 
percentiles of birth 
weight for gestational 
ages for singletons, 
twins, males, females  
 
Authors provide 
separate references for 
singletons and twins but 
make no comment on 
the utility of separating 


















All births in Canada from Jan 1 
1994 through to Dec 31 1996  
(excluding Ontario due to data 
quality) 
 
-data retrieved from “Canadian 
national linked live birth-infant 
death file”  
(linked file was chosen over the 
Canadian Birth Database because it 
allowed for identification and 
removal of duplicates) 
 
-Singletons only 
- no race data available 
 
-N= 347,570 males, 329,035 
females 
 
GESTATIONAL AGE RANGE:  
22-43 weeks  
 
TWINS INCLUDED?: 
Singleton only   
-gestational age derived from 
early ultrasound based 
estimates, and was measured in 
completed weeks  
-gestational age errors and 
implausible values for 
gestational age corrected using 
a mixture distribution method 
 
Maximum likelihood estimates 
derived using estimation 
maximization algorithm to 
determine mean and SD to 
confirm recorded gestational 
ages 
 
-birthweight percentiles per 
gestational age created using a 
smoothing spline with 7 
degrees of freedom   
 
-“bumps” in birthweight 
distribution (most likely due to 
misclassified data) were 
smoothed  
-3rd, 5th, 10th, 50th, 90th, 
95th, and 97th percentile 
birth weight for 
gestational age are 




curves with biologically 
sensible distributions at 
all gestational ages”. 
-Authors recommend 
twins are treated under 
separate growth 
standards from 
singletons, due to 
different birthweight 
specific morbidities and 
mortality in twins and 
singletons  
-Percentile curves 
follow a sigmoid shape  
-LGA cutoff at low 
gestational age is lower 
than currently existing 
standards 




All singleton and twin births at 36-
42 weeks’ gestational age in 
United States from 1995-2002  
N= 17,811,922 
-gestational age based on 
clinical estimate 
 
-3rd, 10th, 90th and 97th 
percentiles are reported 
for females and males, 
singletons and twins.  





























-non white, non black mothers 
-unknown sex, birthweight or 
gestational age 
-improbable birthweight for 
gestational age combinations 
-congenital anomaly (or birth in a 
state that does not report 
anomalies) 
-births ending in neonatal (<28 
days) death  
-missing information 
-serious neonatal morbidity 
-all California births > (do not 
report clinical estimate of 
gestational age) 
 
GESTATIONAL AGE RANGE:  
36-42 weeks  
 
TWINS INCLUDED?: 
Singleton and twin  
-maximum likelihood methods 
to determine cutpoints (related 
to a separate objective) + slope  
 
-no smoothing techniques used 
 
-authors also report 
upper and lower bounds 
of optimal birth weights 
(estimate and 95%CI) 
per gestational age, for 
males and females, 
singletons and twins.  
 
This outcomes based 
approach supports the 
need for separate 
standards for singletons 
and twins  
-authors do not 
recommend separating 
standards by race, 
education, parity, 
















Over 1 million live births 
(singleton and twin) in Canada 
from 1986-1988 
- N= 1,119,440 
-data from computerized birth files 
(official vital statistics registrations 
of live births) 
- live births to Canadian residents 
only  
 
-data on congenital anomalies was 
not available.  
- no patient racial/ethnic 
background data available  
 
GESTATIONAL AGE RANGE:  
22-44 weeks  
 
TWINS INCLUDED?: 
Singleton and twin  
-self-reported gestational age in 
completed weeks was used (in 
Quebec, gestational age was 
physician reported) 
 
-Birth weights were rounded to 
the nearest 10 g 
 
- outliers were determined 
using birthweight relative to 
gestational age 
 
-percentiles calculated in SAS 
using the empirical distribution 
function with averaging 
 
 
-1st, 3rd, 5th, 10th, 25th, 
50th, 75th, 90th, 95th, 97th, 
99th percentiles of 
birthweight were 
reported for 22-44 
weeks gestational age 
-percentiles are reported 
for male and female, 
singleton and twin  
-percentiles are provided 
in chart form – exact 
birth weights per 
gestational age are not 
reported (Authors did 
provide a table of 
birthweight per 
gestational age values 
via email request)  
-Authors report separate 
standards for singletons 
and twins  
-Authors suggest that 
references are updated 
every 5-10 years 







-1781 uncomplicated twin 
pregnancies sourced from 19 
Italian birth centres  
- births from January 2010 to 
December 2015 
1289 dichorionic (DC) twins + 492 
monochorionic (MC) twins   
-gestational age calculated 
using crown –rump length of 
larger twin using the Robinson 
and Fleming equation  
 
-chorionicity determined based 
on sonography results  
-5th, 10th, 50th, 90th, 95th 
percentiles of 
birthweight for 
gestational age reported 
for singletons, 
dichorionic twins, and 
monochorionic, 


















-uncomplicated twin pregnancy + 
known chorionicity 
-first trimester dating via crown-
rump length 
-delivery ≥ 36 weeks 
 
Exclusions:  
-use of assisted reproductive 
technologies 
-structural or chromosomal 
anomalies  
-unknown/uncertain chorionicity 
-monoamniotic (MA) twins 
-fetal reduction 
-maternal smoking/drug use 
-maternal (pre-existing) 
hypertension, diabetes, renal 
disorders, autoimmune disorders  
-development of gestational 
diabetes or pre-eclampsia 
-twin pairs where one twin has a 
birth weight below the bottom fifth 
percentile  
  
GESTATIONAL AGE RANGE:  
16-36 weeks  
 
TWINS INCLUDED?: 
Singleton and twin  
 
-logarithmic transform of 
gestational age for model fitting 
diamniotic twins. Only 
male values are reported 
 
-separate growth curves 
for DC and MC twins, 
and singletons were 





estimated fetal weight  
 
-authors report different 
growth patterns between 
singletons and twins  
-differences were more 
significant in MC twins  
 
-authors support the use 
of customized charts, 
especially when 
diagnosing growth 
restricted infants  
-also support the use of 
charts customized by 
chorionicity when 

















Singleton live births to American 
mothers in 1991  
N= 3,134,879 
 
GESTATIONAL AGE RANGE:  
20-44 weeks  
 
TWINS INCLUDED?: 
Singleton only   
Smoothing techniques (resistant 
non-linear technique – 
“4325H”) used across 
gestational age categories  
 
-imputed gestational age when 
last day of menses is missing  
 
-implausible birth weight for 
gestational age combinations 
were trimmed using gestational 
age specific cutpoints 
-authors report 5, 10, 50, 
90, and 95th percentiles 
for 20-44 weeks (not-
stratified by fetal sex) 
  




10th and 90th birthweight for gestational age percentile values for singletons and twins, males and 
females  
Reference 1: Kramer MS, Platt RW, Joseph KS. A New and Improved Population-Based Canadian Reference for 
Birth Weight for Gestational Age. Pediatrics. 2001;108(613):5995 
Reference 2: Robertson CMT, Svenson LW, Kyle JM. Birth weight by gestational age for Albertan liveborn infants, 
1985 through 1998. J Obstet Gynaecol Can. 2002;24(2):138–48. 
Reference 3: Joseph KS, Fahey J, Platt RW, Liston RM, Lee SK, Sauve R, et al. An outcome-based approach for the 
creation of fetal growth standards: Do singletons and twins need separate standards? Am J Epidemiol. 
2009;169(5):616–24. 
Reference 4: Ghi T, Prefumo F, Fichera A, Lanna M, Periti E, Persico N, et al. Development of customized fetal 
growth charts in twins. Am J Obstet Gynecol. 2017;216(5):514.e1-514.e17. 
Reference 5: Arbuckle T, Wilkins R, Sherman G. Birth Weight Percentiles by Gestational Age in Canada. Obstet 
Gynecol. 1993;81(1):39–48. 





Joseph (2009) Ghi (2017) Arbuckle (1993) 
20 n/a n/a n/a n/a n/a 
21 n/a 320 n/a n/a n/a 
22 385 403 n/a n/a 360 
23 450 468 n/a n/a 450 
24 513 500 n/a n/a 505 
25 578 540 n/a n/a 600 
26 645 640 n/a n/a 650 
27 717 680 n/a n/a 750 
28 802 800 n/a n/a 800 
29 903 963 n/a n/a 910 
30 1022 1040 n/a n/a 1030 
31 1168 1177 n/a n/a 1180 
32 1346 1400 n/a n/a 1350 
33 1548 1542 n/a n/a 1560 
34 1768 1820 n/a n/a 1770 
35 1998 2000 n/a n/a 1970 
36 2227 2225 2255 n/a 2210 
37 2452 2435 2466 n/a 2430 
38 2658 2644 2665 n/a 2640 
39 2825 2800 2835 n/a 2790 
40 2955 2920 2930 n/a 2910 
41 3051 3015 3040 n/a 3010 
42 3114 3045 3062 n/a 3070 
43 3159 2944 n/a n/a 3070 
44 n/a 2990 n/a n/a 2960 
 




Table F.2: Singleton females 90th percentile  
GEST AGE Kramer(2001) Robertson 
(2002) 
Joseph (2009) Ghi (2017) Arbuckle (1993) 
20 n/a n/a n/a n/a n/a 
21 n/a 500 n/a n/a n/a 
22 552 616 n/a n/a 600 
23 669 720 n/a n/a 700 
24 790 790 n/a n/a 855 
25 918 950 n/a n/a 920 
26 1060 1051 n/a n/a 1070 
27 1218 1222 n/a n/a 1220 
28 1390 1453 n/a n/a 1420 
29 1578 1637 n/a n/a 1560 
30 1783 2045 n/a n/a 1800 
31 2004 2030 n/a n/a 1980 
32 2242 2375 n/a n/a 2330 
33 2494 2480 n/a n/a 2550 
34 2761 2820 n/a n/a 2790 
35 3037 3037 n/a n/a 3030 
36 3307 3340 3345 n/a 3360 
37 3543 3530 3572 n/a 3520 
38 3738 3720 3771 n/a 3710 
39 3895 3860 3912 n/a 3860 
40 4034 4000 4025 n/a 4000 
41 4154 4115 4139 n/a 4130 
42 4251 4190 4224 n/a 4200 
43 4333 4276 n/a n/a 4280 
44 n/a 4291 n/a n/a 4120 
 
Table F.3: Singleton male 10th percentile  
GEST AGE Kramer(2001) Robertson 
(2002) 
Joseph (2009) Ghi (2017) Arbuckle 
(1993) 
16 n/a n/a n/a 110 n/a 
17 n/a n/a n/a 145 n/a 
18 n/a n/a n/a 187 n/a 
19 n/a n/a n/a 236 n/a 
20 n/a n/a n/a 292 n/a 
21 n/a 347 n/a 356 n/a 
22 401 431 n/a 427 420 
23 475 475 n/a 507 500 
24 547 539 n/a 595 530 




25 617 599 n/a 690 620 
26 686 680 n/a 794 710 
27 763 765 n/a 905 790 
28 853 900 n/a 1024 880 
29 964 996 n/a 1151 1000 
30 1099 1214 n/a 1284 1150 
31 1259 1219 n/a 1425 1250 
32 1444 1469 n/a 1572 1460 
33 1648 1690 n/a 1725 1630 
34 1866 1874 n/a 1885 1850 
35 2091 2100 n/a 2050 2070 
36 2321 2310 2353 2220 2300 
37 2552 2540 2570 n/a 2530 
38 2766 2760 2778 n/a 2750 
39 2942 2920 2948 n/a 2910 
40 3079 3040 3033 n/a 3030 
41 3179 3150 3175 n/a 3150 
42 3222 3170 3202 n/a 3200 
43 3249 3178 n/a n/a 3220 
44 n/a 3229 n/a n/a 3150 
 
Table F.4: Singleton male 90th percentile  




Ghi (2017) Arbuckle 
(1993) 
16 n/a n/a n/a 155 n/a 
17 n/a n/a n/a 206 n/a 
18 n/a n/a n/a 267 n/a 
19 n/a n/a n/a 338 n/a 
20 n/a n/a n/a 421 n/a 
21 n/a 612 n/a 515 n/a 
22 587 630 n/a 620 630 
23 714 733 n/a 738 770 
24 844 881 n/a 866 850 
25 981 970 n/a 1007 950 
26 1125 1153 n/a 1159 1110 
27 1278 1290 n/a 1321 1250 
28 1445 1545 n/a 1495 1480 
29 1629 1661 n/a 1678 1610 
30 1837 1860 n/a 1871 1880 
31 2069 2082 n/a 2073 2070 
32 2319 2373 n/a 2283 2355 




33 2580 2622 n/a 2501 2600 
34 2851 2855 n/a 2726 2860 
35 3132 3140 n/a 2957 3130 
36 3411 3413 3463 3195 3450 
37 3665 3655 3714 n/a 3640 
38 3877 3865 3912 n/a 3860 
39 4049 4012 4054 n/a 4010 
40 4200 4174 4167 n/a 4170 
41 4328 4300 4309 n/a 4310 
42 4433 4370 4394 n/a 4420 
43 4528 4476 n/a n/a 4480 
44 n/a 4392 n/a n/a 4500 
 
Table F.5: Twin female 10th percentile  
GEST AGE Kramer(2001) Robertson 
(2002) 
Joseph (2009) Ghi (2017) Arbuckle 
(1993) 
20 n/a n/a n/a n/a n/a 
21 n/a n/a n/a n/a n/a 
22 n/a 267 n/a n/a n/a 
23 n/a 358 n/a n/a n/a 
24 n/a 495 n/a n/a n/a 
25 n/a 592 n/a n/a n/a 
26 n/a 580 n/a n/a n/a 
27 n/a 673 n/a n/a n/a 
28 n/a 442 n/a n/a 930 
29 n/a 972 n/a n/a 850 
30 n/a 1080 n/a n/a 1050 
31 n/a 1233 n/a n/a 1230 
32 n/a 1320 n/a n/a 1370 
33 n/a 1450 n/a n/a 1560 
34 n/a 1645 n/a n/a 1610 
35 n/a 1770 n/a n/a 1810 
36 n/a 1958 2040 n/a 1920 
37 n/a 2165 2183 n/a 2120 
38 n/a 2215 2296 n/a 2210 
39 n/a 2327 2353 n/a 2330 
40 n/a 2400 2325 n/a 2360 
41 n/a 2340 n/a n/a 2500 
42 n/a n/a n/a n/a n/a 
43 n/a n/a n/a n/a n/a 
44 n/a n/a n/a n/a n/a 










Joseph (2009) Ghi (2017) Arbuckle 
(1993) 
20 n/a n/a n/a n/a n/a 
21 n/a n/a n/a n/a n/a 
22 n/a 677 n/a n/a n/a 
23 n/a 605 n/a n/a n/a 
24 n/a 863 n/a n/a n/a 
25 n/a 878 n/a n/a n/a 
26 n/a 970 n/a n/a n/a 
27 n/a 1130 n/a n/a n/a 
28 n/a 1200 n/a n/a 1340 
29 n/a 1497 n/a n/a 1500 
30 n/a 1631 n/a n/a 1710 
31 n/a 1833 n/a n/a 1830 
32 n/a 2079 n/a n/a 2060 
33 n/a 2179 n/a n/a 2250 
34 n/a 2430 n/a n/a 2410 
35 n/a 2620 n/a n/a 2630 
36 n/a 2865 2920 n/a 2820 
37 n/a 3039 3085 n/a 3010 
38 n/a 3200 3232 n/a 3230 
39 n/a 3353 3290 n/a 3330 
40 n/a 3532 3345 n/a 3490 
41 n/a 3485 n/a n/a 3460 
42 n/a n/a n/a n/a n/a 
43 n/a n/a n/a n/a n/a 
44 n/a n/a n/a n/a n/a 
 





Joseph (2009) Ghi (2017) Arbuckle 
(1993) 
16 n/a n/a n/a 104 n/a 
17 n/a n/a n/a 137 n/a 
18 n/a n/a n/a 176 n/a 
19 n/a n/a n/a 222 n/a 
20 n/a n/a n/a 275 n/a 
21 n/a  n/a 334 n/a 
22 n/a 364 n/a 401 n/a 
23 n/a 388 n/a 475 n/a 




24 n/a 500 n/a 555 n/a 
25 n/a 588 n/a 642 n/a 
26 n/a 500 n/a 736 n/a 
27 n/a 590 n/a 835 n/a 
28 n/a 780 n/a 942 850 
29 n/a 932 n/a 1053 1060 
30 n/a 1126 n/a 1170 1180 
31 n/a 1242 n/a 1291 1310 
32 n/a 1403 n/a 1417 1440 
33 n/a 1578 n/a 1547 1580 
34 n/a 1710 n/a 1680 1730 
35 n/a 1930 n/a 1816 1900 
36 n/a 2065 2126 1955 2050 
37 n/a 2225 2268 n/a 2180 
38 n/a 2400 2381 n/a 2320 
39 n/a 2440 2448 n/a 2390 
40 n/a 2450 2466 n/a 2390 
41 n/a 2528 n/a n/a 2500 
42 n/a n/a n/a n/a n/a 
43 n/a n/a n/a n/a n/a 
44 n/a n/a n/a n/a n/a 
 





Joseph (2009) Ghi (2017) Arbuckle 
(1993) 
16 n/a n/a n/a 145 n/a 
17 n/a n/a n/a 191 n/a 
18 n/a n/a n/a 246 n/a 
19 n/a n/a n/a 310 n/a 
20 n/a n/a n/a 384 n/a 
21 n/a n/a n/a 469 n/a 
22 n/a 574 n/a 565 n/a 
23 n/a 662 n/a 671 n/a 
24 n/a 750 n/a 789 n/a 
25 n/a 967 n/a 919 n/a 
26 n/a 1090 n/a 1059 n/a 
27 n/a 1153 n/a 1211 n/a 
28 n/a 1420 n/a 1375 1420 
29 n/a 1614 n/a 1550 1600 
30 n/a 1732 n/a 1735 1720 
31 n/a 1920 n/a 1932 1900 
32 n/a 2158 n/a 2139 2100 




33 n/a 2392 n/a 2356 2360 
34 n/a 2532 n/a 2582 2550 
35 n/a 2780 n/a 2818 2780 
36 n/a 2960 3033 3063 2950 
 37 n/a 3170 3204 n/a 3160 
38 n/a 3354 3350 n/a 3380 
39 n/a 3475 3459 n/a 3520 
40 n/a 3588 3487 n/a 3570 
41 n/a 3730 n/a n/a 3890 
42 n/a n/a n/a n/a n/a 
43 n/a n/a n/a n/a n/a 
44 n/a n/a n/a n/a n/a 
 




G: Predictors in the Multivariable Model  
The ‘full’ adjusted models are presented here with an overview of each variables individual effect on the 
outcome of infant odds of being small or large for gestational age. As the primary aim of this thesis was 
not to build an explanatory model, not every possible ‘predictor’ variable was included in the adjusted 
model. This was explored further in the discussion chapter.  The final multivariable model comprised of 
variables explored in the literature review for which there were sufficient sample sizes (i.e. no “zero 
cells”) across each category of Maternal pre-pregnancy BMI for both singletons and twins.  Twin models 
were also more likely to have “zero cells” for potential covariates, again due to decreased sample sizes, 
which prevented the statistical software from generating confidence intervals or p-values for the 
calculated odds ratios. This is also why Underweight mothers were not used in the twin analyses.  
Important to note here is that the overall pattern of Odds Ratios by Maternal BMI category does not 
change considerably before and after adjustment.  Increased maternal BMI is associated with decreased 
odds of giving birth to a small for gestational age infant, with this association achieving statistical 
significance for singleton pregnancies only, and increased maternal BMI is associated with increased odds 
of giving birth to a large for gestational age infant, and this association achieved statistical significance 
for both singleton and twin pregnancies. Overall, the effects of predictor variables on infant odds of small 
for gestational age or large for gestational age varied between singleton and twin pregnancies. The 
variables smoking, hypertensive disorders and preterm birth overall contributed to infant SGA and the 
variables parity, diabetes and carbohydrate disorders overall contributed to infant LGA  
 
Predictor variables  
Parity 
Multiparity decreases the likelihood of SGA, and increases likelihood of LGA in singleton pregnancies 
only in this study population. 
SGA 
Compared to nulliparous mothers, multiparous mothers had 0.66x decreased odds of giving birth to a 
small for gestational age singleton.  There was no evidence to suggest that increased parity was associated 
with odds of SGA in twins in this study population.  
LGA 




Compared to nulliparous mothers, multiparous mothers had 1.57x increased odds of giving birth to a large 
for gestational age singleton, holding maternal BMI and all other predictor variables constant. There was 
no evidence to suggest that increased parity was associated with odds of LGA in twins in this study 
population.  
 
Current (pre-existing) Diabetes 
Diabetes decreased likelihood of SGA, and increased likelihood of LGA in singleton pregnancies only in 
this study population.  
SGA 
There was no evidence to suggest an association between maternal diabetes and infant SGA in either 
singletons or twins in this study population. 
LGA 
Compared to non-diabetic mothers, diabetic mothers had 6.36x increased odds of giving birth to a large 
for gestational age singleton. There was no evidence to suggest an association between maternal diabetes 
and infant LGA in twins in this study population. 
 
Smoking 
Smoking increases likelihood of SGA and decreases likelihood of LGA in singletons only in this study 
population. 
SGA 
Compared to non smokers, smoking mothers have 2.25x increased odds of giving birth to a small for 
gestational age infant, holding maternal BMI and all other predictor variables constant. There was no 
evidence to suggest that an association between smoking and infant SGA exists in twins in this study 
population.  
LGA 
Compared to non smokers, smoking mothers have 0.62x decreased odds of giving birth to a large for 
gestational age infant, hold maternal BMI and all other predictor variables constant. There was no 








Maternal hypertensive disorders increase the likelihood of SGA in both singletons and twins in this study 
population. 
SGA 
Compared to healthy mothers, mothers with any hypertensive disorders have 2.03x increased odds of 
giving birth to a small for gestational age singleton, holding maternal BMI and all other predictor 
variables constant. This is slightly decreased in twin pregnancies; Compared to healthy mothers, 
hypertensive mothers have 1.59x increased odds of giving birth to a small for gestational age twin 
LGA 
There was no evidence to suggest that the associations between maternal hypertensive disorders and 
infant odds of being born large for gestational age were not significant in either singletons or twins.  
 
Carbohydrate disorders 
Carbohydrate disorders increased the likelihood of LGA in singletons in the study population.  
SGA 
There was no evidence to suggest that the association between maternal carbohydrate disorders and infant 
SGA was significant in either singleton or twin populations.  
LGA 
Compared to healthy mothers, mothers with carbohydrate disorders have 1.54x increased odds of giving 
birth to a large for gestational age singleton, holding maternal BMI and all other predictor variables 
constant. There was no evidence to suggest a significant association between carbohydrate disorders and 
LGA in twin pregnancies.  
Preterm birth  




Preterm birth increases odds of SGA, and decreases odds of LGA in singletons only, likely due to 
gestational age being a main component of the size for gestational age measure 
SGA 
Compared to term infants, preterm singletons have 1.33x increased odds of being small for gestational 
age holding maternal BMI and all other predictor variables constant. For twin pregnancies, there was no 
evidence to suggest that an association exists between preterm birth and odds of SGA.  
LGA 
Compared to term infants, preterm singletons have 0.61x decreased odds of being born large for 
gestational age. There was no evidence to suggest that the association between preterm births and LGA 




POTENTIAL STATISTICAL CONFOUNDING  
We also further explored why some odds changed significantly (i.e. greater than 10% change in odds, in 
either increasing or decreasing direction) after adjustment to determine if confounding was present in the 
models. Smoking (singletons), parity and hypertensive disorders (twins) may be potential confounders in 
the association between maternal obesity and infant small for gestational age. Maternal diabetes and 
carbohydrate disorders may be potential confounders in the association between maternal obesity and 
infant large for gestational age – in singletons only. There was no evidence of statistical confounding in 
the model testing the association of maternal obesity on twin odds of being large for gestational age.  
Note that the overall relationships between maternal pre-pregnancy BMI and infant small or large for 
gestational age do not change before and after adjustment, regardless of inclusions of potential 
confounding variables in the model. 
 
Small for Gestational Age:  
Singleton:  
The odds of underweight mothers having an SGA singleton decreased from 1.91 to 1.70 (a decrease of 
11%) after adjustment, and this was likely due to maternal smoking. (i.e. this was seen when maternal 




smoking was entered into the model).  The odds of obese class III mothers giving birth to an SGA 
singleton decreased by 19% from 0.83 to 0.67, likely due to the effect of adding maternal hypertensive 
disorders into the model. 
Twins:  
The odds of obese class III mothers of twins giving birth to an SGA twin increased from 0.32 to 0.38 (an 
increase of 19%), potentially due to the effect of adding maternal parity and hypertensive disorders into 
the model.  
Large for Gestational age:  
Singletons:  
The odds of obese class III mothers having an LGA singleton were reduced significantly from 3.40 to 
2.85 (a 16% decrease), and this was likely due to a combination of maternal diabetes and carbohydrate 
disorders. (i.e. this decrease was seen when maternal diabetes and carbohydrate disorders were entered 
into the model). 
Twins: 
No confounding is readily apparent in the twin LGA model for this study population.  
 
  




Table G.a: Adjusted Odds of being Small for gestational age in singletons and twins using 
Robertson (2002) values – all covariates (male and female combined) 
 
Singleton Twin 
OR (95%CI) P value OR (95%CI) P value 




Obese Class I 
Obese Class II 


























Maternal Pre-Pregnancy Variables 
Parity  0.66 (0.61-0.72) <0.0001 0.81(0.54-1.21) 0.31 
Current (Pre-existing) Diabetes  0.96 (0.60-1.55) 0.87 0.86 (0.19-3.81) 0.84 
Pregnancy-related Variables 
Smoking  2.25 (2.05-2.46) <0.0001 1.36 (0.81-2.30) 0.25 
Hypertensive Disorders 2.03 (1.78-2.31) <0.0001 1.59 (1.01-2.50) 0.04 
Carbohydrate Disorders  1.01 (0.84-1.22) 0.91 0.77 (0.39-1.51) 0.45 
Infant Variables 
Preterm Birth  1.33 (1.14-1.54) 0.0002 1.18 (0.80-1.73) 0.40 
Two tailed Wald test derived p-values and confidence intervals are reported  
*Note that Underweight mothers were omitted from analyses due to zero cells impeding model fit  













Table G.b: Adjusted Odds of being Large for gestational age in singletons and twins using 
Robertson (2002) values – all covariates (female and male combined) 
 
Singleton Twin 
OR (95%CI) P value OR (95%CI) P value 




Obese Class I 
Obese Class II 


























Maternal Pre-Pregnancy Variables 
Parity  1.57 (1.44-1.70) <0.0001 1.33(0.84-2.12) 0.23 
Current (Pre-existing) diabetes 6.36 (4.98-8.12) <0.0001 1.36 (0.26-7.03) 0.71 
Pregnancy-related Variables 
Smoking  0.62 (0.54-0.71) <0.0001 0.49(0.23-1.02) 0.06 
Hypertensive Disorders 1.11 (0.96-1.28) 0.15 1.05(0.61-1.83) 0.85 
Carbohydrate Disorders  1.54 (1.34-1.76) <0.0001 0.86(0.45-1.63) 0.64 
Infant Variables 
Preterm Birth  0.61 (0.50-0.75) <0.0001 1.20(0.79-1.84) 0.39 
Two tailed Wald test derived p-values and confidence intervals are reported  
*Note that Underweight mothers were omitted from analyses due to zero cells impeding model fit  








H: Interaction Between Hypertensive Disorders and Maternal Pre-Pregnancy 
BMI 
 
We also tested for a potential interaction occurring in the model.  The interaction of maternal pre-
pregnancy BMI and maternal hypertensive disorders on the odds of infant small for gestational age or 
large for gestational age were also explored, and there was no evidence of statistical interaction, for all 
comparisons, in either singletons or twins before and after adjustment for relevant confounders. 
There is no evidence to suggest that in this study population, maternal hypertensive disorders influence 
the relationship between maternal obesity and infant size for gestational age.  
 
Table H.a Odds of Singleton Small or Large for Gestational Age due to the Interaction of Maternal 
Pre-pregnancy BMI and Maternal Hypertensive Disorders - Crude 
SGA Wald Statistics For Joint Tests For GEE  
Effect DF Chi-Square Pr > ChiSq 
Small for Gestational Age 
BMI 5 185.0558 <.0001 
Hypertensive Disorders 1 87.3185 <.0001 
BMI* Hypertensive Disorders 5 4.6956 0.4542 
Large for Gestational Age 
BMI 5 478.0064 <.0001 
Hypertensive Disorders 1 0.7515 0.3860 
BMI* Hypertensive Disorders 5 7.5140 0.1851 
 
Table H.b Odds of Singleton Small or Large for Gestational Age due to the Interaction of Maternal 
Pre-pregnancy BMI and Maternal Hypertensive Disorders - Adjusted 
SGA Wald Statistics For Joint Tests For GEE  
Effect DF Chi-Square Pr > ChiSq 
Small for Gestational Age 
BMI 5 130.2384 <.0001 
Hypertensive Disorders 1 72.9120 <.0001 
BMI* Hypertensive Disorders 5 4.6859 0.4554 
Large for Gestational Age 
BMI 5 367.4383 <.0001 
Hypertensive Disorders 1 0.3414 0.5590 
BMI* Hypertensive Disorders 5 7.6252 0.1781 
 




Table H.c Odds of Twin Small or Large for Gestational Age due to the Interaction of Maternal Pre-
pregnancy BMI and Maternal Hypertensive Disorders - Crude 
SGA Wald Statistics For Joint Tests For GEE  
Effect DF Chi-Square Pr > ChiSq 
Small for Gestational Age 
BMI 4 2.42 0.6599 
Hypertensive Disorders 1 2.32 0.1273 
BMI* Hypertensive Disorders 4 2.60 0.6266 
Large for Gestational Age 
BMI 4 11.90 0.0181 
Hypertensive Disorders 1 0.32 0.5727 
BMI* Hypertensive Disorders 4 4.94 0.2936 
 
Table H.d Odds of Twin Small or Large for Gestational Age due to the Interaction of Maternal 
Pre-pregnancy BMI and Maternal Hypertensive Disorders - Adjusted 
SGA Wald Statistics For Joint Tests For GEE  
Effect DF Chi-Square Pr > ChiSq 
Small for Gestational Age 
BMI 4 2.21 0.6980 
Hypertensive Disorders 1 1.71 0.1906 
BMI* Hypertensive Disorders 4 3.36 0.4991 
Large for Gestational Age 
BMI 4 12.02 0.0172 
Hypertensive Disorders 1 0.46 0.4957 
BMI* Hypertensive Disorders 4 4.70 0.3200 
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